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Canis lupus familiaris, the domestic dog, possesses a huge variability in traits such as size, 
conformation, coat color, or character, which reflects the generations of targeted human 
selection after the dog's domestication thousands of years ago. The phenotypic differences 
naturally reflect the underlying, often breed-specific, genetic variation. While heterogeneity 
between breeds is large, at the same time, the individuals within one breed are usually very 
homogeneous. This specific population structure of modern dog breeds with low genetic 
diversity favors the propagation of spontaneous occurrences of genetic mutations that might 
lead to the development of diseases, and thus makes the dog a valuable animal model. 
Inherited neurological disorders in animals as well as in human patients are incurable, often 
severe, and result in progressively worsening quality of life; early diagnosis is therefore 
beneficial for managing the disease development. DNA-based precision medicine using state-
of-the-art methods, e.g. whole-genome sequencing (WGS) has been successfully utilized in 
recent years for routine diagnosis of rare diseases in human as well as in veterinary medicine. 
Identification of disease-causing variants allows dog breeders to avoid the spread of such 
variants in the affected dog breed, ultimately improving the health of the whole population 
through better breeding management, as well as to advance the understanding of the 
molecular mechanisms involved in corresponding human disease, and may be useful for the 
development of novel therapeutic strategies. 
In this thesis, I took part in the analysis of seven specific canine neurological phenotypes 
applying different genetic mapping methods, candidate gene analysis, and WGS. I also 
generated and analyzed extensive genealogical and genomic data on the worldwide 
Leonberger dog population in regards to its diversity and disease prevalence. Despite its 
increasing size in recent years, the population lost considerable genetic diversity due to a 
bottleneck in the last century. The heavy use of popular sires led to high relatedness among 
the breeding dogs and thus to high inbreeding rates. This facilitated undesirable genetic traits 
to spread within the gene pool of the Leonberger breed. A private homozygous frameshift 
variant in the GJA9 gene was identified in Leonbergers with an adult-onset form of 
polyneuropathy using genome-wide association study (GWAS) and WGS. The GJA9 gene 
encodes a connexin gap junction family protein, which are important components of peripheral 
myelinated nerve fibers; this discovery for the first time adds GJA9 to the list of candidate 
genes for similar human conditions. During a study of additional forms of polyneuropathy 
and/or laryngeal paralysis, I found a missense variant in the CNTNAP1 gene in Leonbergers 
and Saint Bernards showing early signs of laryngeal paralysis. CNTNAP1 encodes a contactin-
associated protein important for the organization of myelinated axons and has been implicated 
in various forms of human neurological diseases. Interestingly, this variant was seen in several 
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other unrelated dog breeds and most likely predates modern breed establishment. A similar 
approach revealed two independent variants in the NAPEPLD gene in Leonberger and 
Rottweiler dogs affected by leukoencephalomyelopathy providing evidence for allelic 
heterogeneity of this disorder and the first description of NAPEPLD-associated inherited 
defects in the endocannabinoid system associated with myelin disorders. In another study, a 
form of canine neuroaxonal dystrophy occurred in young adult Rottweiler dogs. WGS data of 
two cases revealed a homozygous missense variant in the VPS11 gene, encoding a member 
of VPS class C complex, a key factor of the endosome-autophagosome-lysosome pathway, 
previously associated with an infantile-onset neurological syndrome in humans. In a family of 
Alpine dachsbracke dogs, I used linkage analysis and homozygosity mapping to discover an 
autosomal recessive variant in the puppies affected by spinocerebellar ataxia, which affects 
the SCN8A gene. The gene encodes a subunit of a channel important for sodium ion transport 
to neurons in the central nervous system and was previously implicated in human neurogenetic 
conditions. By in-depth pedigree analysis, I found a common ancestor of two geographically 
separated families of Saluki dogs in which puppies suffering from succinic semialdehyde 
dehydrogenase deficiency causing neurological abnormalities were observed. GWAS and 
subsequent filtering of WGS data of two affected Saluki cases identified a causative variant in 
the ALDH5A1 gene encoding an essential enzyme of the gamma-aminobutyric acid 
neurotransmitter metabolic pathway. Finally, the underlying genetics of a previously described 
Leigh-like subacute necrotizing encephalopathy in Yorkshire terriers was solved by discovering 
a perfectly associated loss-of-function indel variant in the SLC19A3 gene encoding thiamine 
transporter 2, which is important in brain development, and its disruption was previously seen 
in similar human neurometabolic disease. 
In conclusion, the discovery of the herein described likely pathogenic DNA variants enabled 
systematic genetic testing of breeding dogs, and selection against the corresponding disorders 
to improve the health and welfare of the respective populations. This thesis provides molecular 
descriptions of several canine neurological conditions and presents additional physiologically 
relevant models of corresponding human diseases. Apparently, species- and site-specific 
differences in pathological phenotypes for mutations within the same gene exist as seen, e.g. 
in canine VPS11-related neuroaxonal dystrophy. All these spontaneous canine models closely 
resemble rare human syndromes and provide physiologically relevant models to better 
understand poorly characterized gene functions, e.g. in defects of the endocannabinoid system 
related to NAPEPLD; and provide potential new candidate genes for corresponding human 
forms of diseases with yet unsolved genetic etiology, e.g. GJA9-associated polyneuropathy. 
Therefore, this thesis demonstrates that genomic studies of domestic animal species such as 
the dog improve the understanding of rare complex and heterogeneous groups of 
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Hundreds of distinct dog breeds were formed due to human selection and breeding towards 
specific characteristics since the domestication of dogs. This development ultimately led to the 
most phenotypically diverse mammal known [1]. During the process, some breed-defining 
genetic variants underlying particular phenotypic traits such as size, shape, coat type and 
color, or certain behavior became fixed in the modern breeds. However, artificial selection of 
purebred mating pairs resulted not only in the desired and often unique phenotypes, but also 
led to reduced genetic diversity in the closed breeding populations that eventually increased 
the risk of developing an inherited disease [2]. While historically dogs served predominantly as 
herders, guardians, or hunters, nowadays they are largely considered assistants, companions, 
and family members. Therefore, the breeders and owners are increasingly more interested in 
the health of their dogs including the genetic background of various disorders. Thanks to the 
public availability of annotated canine genome sequence and the constant development of 
advanced molecular genetics methods, as well as the active participation of dog owners, all 
kinds of genotype-phenotype relationships can be studied. 
Dog as animal model 
Humans first domesticated the dog from wolf more than 15,000 years ago [3]. Archeological 
and molecular genetic data found that the domestication events happened more than once in 
different places, and dogs have followed human migration ever since [4,5]. While natural 
selection happens unintentionally when animals adapt to a changing environment, artificial 
selection is a process conducted by people during domestication in order to tame wild animals 
[6]. The popularity and rapid spread of the dog resulted in divergent populations and 
development of specialized breeds. Over the last few centuries, extreme phenotypic 
diversification of the species led to the creation of hundreds of dog breeds able to herd, guard, 
hunt, or guide [1,7–9]. Initially, the selection focused mainly on behavioral characteristics to 
create the most valuable working dogs. Later, morphological appearance became important 
and the strong selection pressure for a specific size, coat type, or color resulted in impressive 
variability among the breeds. In the 19th century, breeding became more restrictive when 
studbooks for most breeds were closed, and the different populations were reproductively 
isolated, forming so-called modern dog breeds [1]. 
Today, the Fédération Cynologique Internationale (the World Canine Organisation) recognizes 
353 registered breeds and maintains their standards [10]. This phenotypic variability is 
accompanied by specific changes in canine genetic architecture. Research of the genetic 
differences improves our understanding of the canine's diverse history, as well as the 
underlying molecular mechanisms of different traits and diseases. Restrictive breeding 
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practices, combined with the use of popular sires (i.e. preferential breeding with only a few 
individuals, especially males), along with frequent inbreeding have all increased within-breed 
relatedness, reflecting the decreased genetic diversity as many modern breeds descend from 
only a limited number of founders. As a consequence, high heterogeneity can be found 
between breeds, while homogeneity exists within breeds. The short generation times and line- 
or inbreeding to maintain breed standards lead to a higher rate of emergence of heritable 
recessive diseases compared to humans. Spontaneous mutants in purebred populations with 
such unique structure make the dog a valuable model for human disorders [11]. 
In addition to physiological and clinical similarity of canine and human conditions, pet dogs 
also share a common environment with their owners, making them a highly valuable large 
animal model [12]. The freely available database Online Mendelian Inheritance in Man (OMIM) 
contains comprehensive information on human genes, and genetic traits and disorders with a 
focus on the genotype-phenotype relationship and currently shows over 25,000 entries [13]. 
Spontaneously occurring canine common or rare diseases are highly similar to their human 
counterparts and are often caused by variants in genes that are orthologous to the human 
genes [12]. The public catalog Online Mendelian Inheritance in Animals (OMIA) currently 
records a total of 787 canine traits or disorders, of which 474 are classified as potential models 
for human disease with 245 records having gene associations [14]. Kennel clubs of purebred 
breeds usually keep detailed pedigree records, and often also additional health information for 
each privately-owned dog. Active participation of breeding organizations and individual owners 
and veterinarians in research is essential for discovery of affected dogs, and subsequent 
identification of deleterious variants associated with their disease. Many purebred dogs appear 
to have an increased risk of certain disorders suggesting a genetic predisposition [15]. 
The size of the dog genome is estimated to be 2.4 Gb and is organized in 38 pairs of 
autosomes and two sex chromosomes. Similarly to the number in human, ~22,000 protein-
coding genes are estimated to be present in the canine genome [16]. Since the whole 
sequence of the dog genome became available in 2005 [17], advanced sequencing technology 
and improved bioinformatics methods have eased the genetic discovery, allowing identification 
of more than 400 likely causal variants associated with diseases and traits in the domestic dog 
[14]. Even despite large population sizes of some popular dog breeds, their genetic diversity 
remains limited. This fact makes them a powerful tool to study genetic etiology of not only 
simple Mendelian, but also of more complex heterogeneous disorders, such as cancers or 
neurodegenerative diseases [18]. 
Similar to human clinical genetics [19], DNA-based precision medicine using available genomic 
information has been proven suitable for diagnosing rare diseases in veterinary medicine [20] 
due to the unprecedentedly high level of medical care standards available for companion 
animals. Finally, the discovery of causative variants enables the development of genetic tests, 
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which are used by dog breeders worldwide to stop the spread of inherited diseases and 
improve the overall health of the respective breeds, while maintaining what genetic diversity 
exists within the breed. Additionally, the molecular characterization of rare diseases in these 
affected animals might help in explaining unsolved cases of similar human diseases. 
Inherited neurological diseases 
Neurodegenerative disorders represent a heterogeneous group of diseases affecting the 
central (CNS) and/or peripheral nervous system (PNS) with the most prominently affected cell 
type being the neuron (Figure 1). 
Numerous neurological diseases have been described in humans, as well as in animals, and 
their molecular characterization improved in recent decades [21]. Diseases of the CNS include 
myelin disorders, encephalopathies, cerebellar degeneration, neuroaxonal dystrophy, and 
ataxias [22]. Peripheral neuropathies, disorders of the PNS, are one of the most common 
neurogenetic diseases, and can be distinguished depending on which part of the nerve is 
affected [23]. All these disease groups may overlap with the classification of neurometabolic 
disorder when a metabolic pathway is affected [24]. 
As in human medicine, neuropathic disorders in dogs often lead to severe phenotypes that 
negatively impact the quality of life and result in progressive lifelong disabilities, or even 
premature death because of the lack of effective treatment [25]. While some of these disorders 
are more common but may present differently (e.g. variable progression of clinical signs and 
ages of onset) across breeds, others are rare and occur in breeds that appear predisposed to 
Figure 1. Schematic representation of canine nervous system. (A) Central nervous system consists of 
brain and spinal cord, while peripheral nervous system represents the nerves connecting rest of the 
body to the CNS. (B) Structure of a typical neuron with myelinated axon. 
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particular forms of these diseases, with many conditions showing complete breed specificity 
[15]. This is most likely due to the limited genetic diversity and high relatedness levels and 
inbreeding within the modern breeds. State-of-the-art genomic tools efficiently characterize the 
DNA variants and may uncover novel molecular pathways involved in such diseases, 
highlighting the advantages of the dog model [26]. 
Neuropathies 
Hereditary peripheral neuropathies (OMIM PS118220, PS162400) are a large group of 
neurological diseases characterized by length-dependent progressive degeneration of the 
PNS with considerable phenotypic and genetic heterogeneity [26]. Charcot-Marie-Tooth 
disease (CMT) is globally the most common form of inherited neuropathy in humans with an 
estimated prevalence of 1:2,500. It is classified as hereditary motor and sensory neuropathy, 
describing its main symptoms: progressive muscle weakness and sensory loss. Additionally, 
patients often develop foot deformities, musculoskeletal complications (e.g. hip dysplasia, 
scoliosis), and some forms also affect cranial nerves and respiratory function [27]. 
In addition to CMT, hereditary neuropathy with liability to pressure palsies, hereditary motor 
neuropathies, and hereditary sensory and autonomic neuropathies are recognized and may 
be complicated by additional neurologic and non-neurologic features. Most of these subgroups 
show genetic heterogeneity, with a known association of around 100 genes, which is also 
reflected in a variety of inheritance patterns and involvement of diverse molecular 
pathomechanisms [28]. More than 30 genes have been implicated in CMT alone. However, 
only four genes (PMP22, MPZ, GJB1, and MFN2) explain over 90% of genetically confirmed 
cases of CMT [29,30]. The rate of detection of causal variants varies greatly, from as low as 
10% in hereditary motor neuropathies to up to 80% in demyelinating forms of CMT. The use 
of modern sequencing technologies is becoming the standard in precision medicine for the 
evaluation of known neuropathy genes and the detection of novel variants in patients with 
unexplained pathology [28]. 
Many canine inherited peripheral polyneuropathies with or without laryngeal paralysis (LPPN) 
(OMIA 001292, 001206) show similarities to human CMT [31]. Laryngeal paralysis may 
develop as part of a polyneuropathy complex and occurs when normally mobile laryngeal 
cartilages become immobile and dysfunctional due to damage to the recurrent laryngeal nerve. 
This leads to respiratory obstruction, noisy and distressed breathing, as well as reduced 
exercise and heat tolerance [32]. It is often treated surgically by unilateral arytenoid 
lateralization surgery to improve breathing and, therefore, quality of life. However, it may 
increase the risk of lifelong complications, such as aspiration pneumonia [33]. Different forms 
of motor and sensory neuropathies often have comparable clinical and histopathological 
features, including gait abnormalities, muscle atrophy, laryngeal paralysis, bark changes, 
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excessive panting or swallowing difficulties, and severe nerve fiber loss resulting from chronic 
axonal degeneration and myelin sheath degradation [34]. Sensory and autonomic 
neuropathies are less frequent but also described in dogs that often exhibit automutilation 
syndrome with insensitivity to painful stimuli [26]. Currently, variants in nine genes are recorded 
in OMIA [14] for various forms of neuropathy in several dog breeds (Table 1). 
Table 1. A list of breeds representing selected forms of canine neuropathies (OMIA#), for which the 
genes harboring candidate causative variants are described, and human disorders (OMIM#) caused by 
variants in the corresponding orthologs, if known. 
Breed MOI1 Associated gene Variant
2 OMIA# [14] Human diseases 
OMIM# 
[13] 
Polyneuropathy and/or laryngeal paralysis 
Leonberger 
Saint Bernard ? ARHGEF10 SS 001917 






AR CNTNAP1 MS 002301 
Congenital hypomyelinating 
neuropathy 
Lethal congenital contracture 
syndrome 
602346 













001970 Warburg micro syndrome 602536 
Miniature bull 
terrier MF RAPGEF6 SS 002222 unknown 610499 
Miniature 
schnauzer AR SBF2 SS 002284 CMT 607697 
Sensory neuropathy 
Border collie 
mixed breed AR FAM134B SS 002032 
Hereditary sensory and 
autonomic neuropathy 613114 
Golden 
retriever MT tRNA-Tyr FS 001467 Exercise intolerance 590100 
1 MOI = mode of inheritance as follows: AR = autosomal recessive, AD = autosomal dominant, 
MT = mitochondrial, MF = multifactorial, ? = unclear. 
2 Type of variant as follows: MS = missense, FS = frameshift, SS = splice-site variant. Multiple entries 
correspond to different variant types found in respective breeds. 
Myelin disorders 
Myelin sheaths are formed by neuroglia and cover the axon of many neurons in the CNS as 
well as PNS. They differ in origin, but share similar structure and function, i.e. to help increase 
the speed of axonal transmission of neural impulses. The nodes of Ranvier form short 
segments of the axon not covered by myelin (Figure 1), where ion channels are located and 
are critical to the normal function [35]. Extensive damage and loss of myelin are followed by 
degeneration of the axon and often also the cell body; this interrupts nerve transmission and 
results in forms of polyneuropathy in PNS or white matter diseases in CNS [36]. Primary myelin 
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disorders of CNS are caused by defects in myelin formation and/or its maintenance and may 
be grouped into dysmyelinating, hypomyelinating, and spongiform disorders [37]. 
In human patients, heritable white matter diseases, or leukodystrophies (OMIM PS312080), 
are classified based on neuroimaging and exhibit a wide range of progressive clinical signs 
including ataxia, spasticity, dysmetria, or developmental delay. More than 30 distinct disorders 
meet the defined criteria of the consensus definition of leukodystrophy, while more than 60 
other disorders are classified as genetic leukoencephalopathies as a broader group with 
heterogeneous clinical and pathological manifestations [38]. In some instances, because of 
the close connection between neuroglia and neurons/axons, it may be difficult to differentiate 
between a process that primarily affects the myelin (strict leukodystrophy) and a process that 
primarily affects the grey matter (genetic leukoencephalopathy), especially when the pathology 
is unclear and performed at the advanced stage of the disease [39]. Recent studies show that 
almost half of all patients whose clinical manifestations and neuroimaging indicate an inherited 
white matter disease do not receive a specific diagnosis with pathogenic variant, even when 
genetic screening of more than 100 leukoencephalopathy-related genes is performed [40,41]. 
Similar myelin disorders are also known in animal species, including dogs [22,42,43]. Canine 
forms of this rare group of disorders include several types of myelopathy with lysis of the white 
matter (Table 2). The age of onset, progression, and severity varies greatly between the 
different myelin disorders [36,44]. For example, degenerative myelopathy is most common in 
older dogs who show axonal and myelin degeneration in the spinal cord, as well as 
hypomyelination and secondary demyelination in peripheral nerves. The clinical signs include 
hyporeflexia, slowly progressive paresis, and spasticity in the pelvic limbs, with general 
proprioceptive ataxia [45]. Leukodystrophies and leukoencephalomyelopathies are examples 
of infantile- or juvenile-onset neurodegenerative disorders characterized by progressive 
neurological worsening, gait abnormalities, especially in the thoracic limbs, and generalized 
weakness, spasticity, ataxia, and loss of conscious proprioception. Affected dogs usually have 
characteristic lesions in the spinal cord white matter, while peripheral nerve and muscle 
biopsies remain generally unremarkable [46,47]. The historical reports of individual cases and 
lack of precise classification reflect the heterogeneity of such disorders termed as 
leukodystrophy, leukoencephalomyelopathy, necrotizing myelopathy, hypomyelination of the 
CNS, or degenerative myelopathy. The mode of inheritance is mostly autosomal recessive, 




Table 2. A list of breeds representing selected forms of canine myelin disorders (OMIA#), for which the 
genes harboring candidate causative variants are described, and human disorders (OMIM#) caused by 
variants in the corresponding orthologs, if known. 
Breed MOI1 Associated gene Variant




Standard schnauzer AR TSEN54 MS 002215 Pontocerebellar hypoplasia 608755 
Cairn terrier 
Irish setter 






000578 Krabbe disease 606890 
Hypomyelination of the central nervous system 
Weimaraner AR FNIP2 FS 000526 unknown 612768 
Leukoencephalomyelopathy 
Australian cattle dog 
Shetland sheepdog MT CYTB MS 001130 
Encephalopathy 










001788 unknown 612334 
Degenerative myelopathy 






Pembroke Welsh corgi 
Rhodesian ridgeback 
AR SOD1 (SP110) MS 000263 
Amyotrophic lateral 
sclerosis 
Spastic tetraplegia and 
axial hypotonia 
147450 
1 MOI = mode of inheritance as follows: AR = autosomal recessive, MT = mitochondrial. 
2 Type of variant as follows: MS = missense, FS = frameshift, IFI = in-frame insertion. Multiple entries 
correspond to different variant types found in respective breeds. 
Neuroaxonal dystrophies 
Neuroaxonal dystrophy (NAD) represents a clinically and genetically heterogeneous group of 
rare diseases of CNS development, with motor neuron degeneration characterized by localized 
axonal swelling and secondary myelin changes [48]. NAD in humans (OMIM PS234200) are 
mostly infantile or juvenile diseases diagnosed histopathologically by the formation of 
dystrophic axons seen as large spheroids mostly in the grey matter in the brain and spinal cord 
[49]. The clinical signs include progressive ataxia, paraplegia, hypermetria, proprioceptive 
deficits, head incoordination, and tremors. Due to neuromuscular dysfunction leading to joint 
contracture and respiratory failure, this condition is often lethal [50]. Nine forms of NAD are 
described in humans and termed neurodegeneration with brain iron accumulation (NBIA) or 
infantile neuroaxonal dystrophy (INAD) following mostly autosomal recessive, but also 
autosomal dominant and X-linked dominant inheritance. The genetic basis of NBIA/INAD is 
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known in about 85% of patients and involves variants in eight genes (PANK2, PLA2G6, FTL, 
C19orf12, WDR45, COASY, REPS1, and CRAT) [48]. 
In veterinary medicine, NAD has been described previously in numerous species 
(OMIA 000715). However, the underlying genetic etiology is currently known only in sheep [51] 
and dogs [52–54]. The affected dogs present typical early onset of signs such as hypermetria 
of thoracic limbs, nystagmus, ataxia, behavioral deficits, and progressive limb paralysis. 
Although some species differences are described, such as lack of brain iron accumulation in 
dogs compared to humans, common pathological pathways are involved in the disease [22]. 
Three of the four canine breed-specific forms are associated with genes in which variants are 
found associated with different human disorders such as neuropathies, paraplegia, or 
leukodystrophy (Table 3). 
Table 3. A list of breeds representing selected forms of canine neuroaxonal dystrophies (OMIA#), for 
which the genes harboring candidate causative variants are described, and human disorders (OMIM#) 
caused by variants in the corresponding orthologs, if known. 
Breed MOI1 Associated gene Variant





Beagle cross AR MFN2 IFD 002153 
CMT 
Hereditary motor and sensory 
neuropathy 
608507 






dog AR TECPR2 MS 001975 Spastic paraplegia 615000 
Rottweiler AR VPS11 MS 002152 Hypomyelinating leukodystrophy 608549 
1 MOI = mode of inheritance as follows: AR = autosomal recessive. 
2 Type of variant as follows: MS = missense, IFD = in-frame deletion. 
Spinocerebellar ataxias 
Ataxia is a relatively non-specific clinical sign of uncoordinated movements. This might lead to 
confusion and therefore, standardized terminology has been proposed to distinguish the 
complex spinocerebellar degenerative disorders in human medicine. This group includes 
hereditary cerebellar ataxias (HCA) and hereditary spastic ataxias (SPAX) mostly subdivided 
according to the mode of inheritance and the mutated gene, although some conditions may 
overlap [21]. More than 70 forms of autosomal dominant (OMIM PS164400) and autosomal 
recessive (OMIM PS213200) spinocerebellar ataxias are described to date, with more than 60 
implicated genes. The definitions are even more complicated by the obvious pleiotropy when 
a mutation in the same gene may induce various phenotypes [55]. HCA are associated with 
cerebellar degeneration, and the disease signs include imbalance, poor hand-eye 
coordination, visual loss, seizures, behavioral symptoms, and peripheral neuropathy [56]. 
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In dogs, phenotypically similar neurodegenerative disorders are described as either cerebellar 
or spinocerebellar ataxia in several breeds. The classification is currently based mainly on 
clinicopathological features and lacks clear consensus, which might lead to misdiagnosis. Due 
to the cerebellar dysfunction, the affected dogs typically show rapidly progressing generalized 
ataxia, tremors, and general failure to thrive [57]. So far, causative variants in twelve genes 
have been described, clearly showing the locus heterogeneity of this phenotype (Table 4). 
Table 4. A list of breeds representing selected forms of canine hereditary ataxias (OMIA#), for which 
the genes harboring candidate causative variants are described, and human disorders (OMIM#) caused 
by variants in the corresponding orthologs, if known. 
Breed MOI1 Associated gene Variant




Parson Russell terrier AR CAPN1 MS 001820 Spastic paraplegia 114220 
Italian spinone AR ITPR1 IRE 002097 Gillespie syndrome Spinocerebellar ataxia 147265 
Alpine dachsbracke AR SCN8A MS 002194 
Myoclonus 
Cognitive impairment with 





Belgian shepherd AR SLC12A6 FS 002279 
Agenesis of the corpus 
callosum with peripheral 
neuropathy 
604878 
Beagle AR SPTBN2 FS 002092 Spinocerebellar ataxia 604985 
Cerebellar ataxia 
Belgian shepherd AR ATP1B2 SS 002110 unknown 182331 
Coton de Tulear AR GRM1 SS 000078 Spinocerebellar ataxia 604473 
Norwegian buhund AR KCNIP4 MS 002240 unknown 608182 
Belgian shepherd 
Jack Russell terrier 
Parson Russell terrier 














AR RAB24 MS 001913 unknown 612415 
Finnish hound AR SEL1L MS 001692 unknown 602329 
Hungarian vizsla AR SNX14 SS 002034 Spinocerebellar ataxia 616105 
1 MOI = mode of inheritance as follows: AR = autosomal recessive. 
2 Type of variant as follows: MS = missense, FS = frameshift, SS = splice-site variant, IRE = intronic 
repeat expansion. Multiple entries correspond to different variant types found in respective breeds. 
Neurometabolic disorders 
Neurometabolic disorders, including various forms of storage diseases, are inborn errors of 
metabolism (IEM), a group of diseases caused by an enzyme deficiency in a metabolic 
pathway. Individually these diseases are rare, but as a group, they are relatively common, with 
more than 500 IEMs reported in human medicine. Accumulation of toxic compounds due to 
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defects in intermediary metabolic pathways, energy deficiency related to mitochondrial 
respiratory chain defects, and defects in the synthesis of complex molecules in certain cellular 
organelles are the main disease-causing mechanisms [58]. About a quarter of IEMs manifests 
in the first few weeks of age, but the clinical signs may also present later in childhood or even 
much later in adulthood, depending on the enzyme deficiency and involved pathway. IEMs are 
challenging to diagnose because the signs are usually non-specific, and may include 
decreased activity, movement abnormalities, mental retardation, developmental delay, 
respiratory distress, lethargy, or seizures [59]. Genes involved in IEMs encode enzymes, 
cofactors, or transmembrane transporters. The absence or abnormal function of these proteins 
results in deficiency or accumulation of specific metabolites, which may lead to lysosomal 
storage disorders. Most neurometabolic disorders are autosomal recessive, but autosomal 
dominant and X-linked forms are also known. Furthermore, different mutations in the same 
gene may result in a wide phenotypic spectrum of diseases [24]. Due to the progressive 
neurologic deterioration involved in many IEM, the classification of some disorders overlaps 
with other grouping systems, such as several neuropathies, encephalopathies, spinocerebellar 
ataxias, NAD, as well as myelin disorders [60]. 
Various canine neurodegenerative conditions resemble the human neurometabolic disorders, 
e.g. thiamine-responsive dysfunction syndrome (OMIM PS249270), succinic semialdehyde 
dehydrogenase deficiency (OMIM 271980), mucopolysaccharidosis (OMIM PS607014), or 
neuronal ceroid lipofuscinosis (OMIM PS256730). These disorders generally show 
considerable phenotypic and genetic heterogeneity with similar health problems as in human 
patients (Table 5). Therefore, studying these naturally occurring dog models furthers the 
understanding of such a complex group of disorders and the biochemical and molecular 
pathogenesis [61]. 
Table 5. A list of breeds representing selected forms of canine neurometabolic disorders (OMIA#), for 
which the genes harboring candidate causative variants are described, and human disorders (OMIM#) 
caused by variants in the corresponding orthologs, if known. 
Breed MOI1 Associated gene Variant
2 OMIA# [14] Human diseases 
OMIM# 
[13] 
Leigh-like subacute necrotizing encephalopathy 
Alaskan husky 
Yorkshire terrier AR SLC19A3 FS 001097 
Thiamine metabolism 
dysfunction syndrome 606152 
Succinic semialdehyde dehydrogenase deficiency 





Neurodegenerative vacuolar storage disease 
Lagotto Romagnolo AR ATG4D MS 001954 unknown 611340 




Breed MOI1 Associated gene Variant













000666 Mucopolysaccharidosis 611542 
Brazilian terrier 








000664 Mucopolysaccharidosis 252800 
Schipperke AR NAGLU FS 001342 CMT Mucopolysaccharidosis 609701 
Dachshund 
Huntaway dog AR SGSH 
IFD 
FS 001309 Mucopolysaccharidosis 605270 
Neuronal ceroid lipofuscinosis (NCL) 
Australian cattle dog 




Spastic paraplegia 610513 







001482 NCL 608102 













001506 NCL 607837 
American bulldog AR CTSD MS 001505 NCL 116840 
Chihuahua 
Chinese crested dog AR MFSD8 FS 001962 
NCL 
Macular dystrophy with 
central cone involvement 
611124 
Dachshund 
Italian cane corso AR PPT1 
FS 
SS 001504 NCL 600722 
Dachshund AR TPP1 FS 001472 NCL Spinocerebellar ataxia 607998  
1 MOI = mode of inheritance as follows AR = autosomal recessive. 
2 Type of variant as follows MS = missense, NS = nonsense, FS = frameshift, SS = splice-site variant, 
SL = loss of the canonical start codon, EGD = deletion of the entire gene, IFD = in-frame deletion. 




Selected methods in genomic analyses 
In the late 20th century, the applications of DNA-based diagnostics in animals included 
cytogenetic and chromosomal techniques for individual identification, parentage control, and 
discovery of deleterious alleles in inherited disorders [62]. Biological knowledge of the specific 
disorder and its underlying etiology was a prerequisite for identifying the causal variant in 
candidate gene approaches. In the 1990s, the first canine genetic linkage map was developed 
by typing 150 microsatellite markers as a hypothesis-free approach for mapping trait-
associated loci [63]. 
More recently, species-specific single nucleotide polymorphism (SNP) arrays based on 
simultaneously genotyping thousands of markers with known chromosomal positions have 
become a routine tool in the field of genetics [64]. This enabled rapid mapping of various traits 
by methods of linkage [65], homozygosity [66], and genome-wide association studies (GWAS) 
[67,68]. Lastly, major improvements in molecular biology and computer science in the 21st 
century allowed the whole-genome sequencing (WGS) technologies to become a powerful 
routine tool in personalized and precision medicine for humans, as well as companion animals, 
such as dogs [69,70]. 
The types of canine variants implicated in disease range from single-nucleotide variants 
(i.e. substitutions, insertions, or deletions of 1 bp) [71–74] through small indels (i.e. insertions 
and deletions of <50 bp) [75,76] to complex large structural variants (i.e. genomic 
rearrangements and copy number variation) [77–79], and may be efficiently identified with SNP 
array genotyping and/or WGS of individuals, families, or large populations. 
In this thesis, a combination of relevant methods has been utilized for mapping, detection, and 
validation of putative disease-causing genetic variants based on each project's hypothesis that 
slightly differed due to observed family structure and available samples. 
Single nucleotide polymorphism (SNP) genotyping arrays 
Canine geneticists were among the first to drive the production of high-quality SNP genotyping 
arrays for companion animals. The polymorphic SNPs were selected from a 2.5 million SNP 
map generated as part of the dog genome project [17] and allowed several large-scale SNP 
genotyping platforms to emerge. These platforms enabled the study of the population structure 
within and across different dog breeds, as well as genetic variation associated with common 
and rare diseases relevant to humans. The earliest array versions established around 2007 
contained as low as 1,500 SNP markers, and later extended to 22k, 27k, or 49k by different 
manufactures. In 2011, a high-density SNP array with 172k SNPs was developed in 
collaboration with the LUPA consortium [80]. The most common currently used versions have 
220k (CanineHD BeadChip, Illumina, San Diego, CA, USA) or 710k markers (Axiom CanineHD 
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Array, Thermo Fisher Scientific, Waltham, MA, USA). In addition, high-quality imputation from 
a lower to a higher level of SNP array density or even to a whole-genome sequencing density 
is possible and has been shown successfully in dogs [81,82]. 
Linkage analysis 
Genetic linkage analysis is a mapping approach used to examine the segregation of a 
particular trait in a given pedigree and to identify chromosomal regions harboring the gene 
responsible for the studied trait. Linkage and recombination are key concepts in the parameter-
based and parameter-free linkage analysis [83]. Genetic linkage occurs when two loci are 
inherited together due to their proximity more often than expected by chance. Two loci 
separated by one centimorgan (corresponding to approximately one million base pairs) have 
a chance of 1% to be separated during a recombination event in one meiosis. With each 
separation, non-random association of alleles of two loci (the linkage disequilibrium) decreases 
and only persists over generations if the two loci are physically close to each other [84]. In 
parameter-based linkage analysis, the co-segregation of genetic markers and a trait is studied 
under a specific model based on known information about mode of inheritance and penetrance. 
Parameter-free linkage analysis studies the probability of alleles being identical by descent 
and does not require a mode of inheritance to be specified [83]. 
The power of linkage between the trait and marker loci is commonly assessed by the LOD 
(logarithm of the odds) score. Generally, a LOD score of higher than 3 is understood as 
genome-wide significant evidence for linkage, while a LOD score of lower than -2 excludes 
linkage. However, the genome-wide significance threshold is of less concern when using 
whole-genome sequencing data as it allows for relatively easy study of even multiple regions 
with only suggestive LOD scores obtained in small pedigrees [84]. 
Runs of homozygosity 
Homozygosity, also known as autozygosity, mapping is a powerful method based on the 
hypothesis that an individual inherited two copies of an allele from a common ancestor. In 
dogs, inbreeding and high relatedness within breeds contribute to a high number of long 
genomic regions that are homozygous [85]. Subsequently, this method is most useful for 
detecting the disease-associated alleles in monogenic autosomal recessive disorders. The 
putative disease locus is typically flanked by a few kilobases (kb) to several megabases (Mb) 
of identical-by-descent markers because chromosomal regions tend to be transmitted 
together. Both SNP array genotyping or WGS data can be investigated for such extended 
regions of homozygosity, also known as runs of homozygosity (ROH) [86]. Rarely, a disease 
may be caused by compound heterozygous variants in a consanguineous pedigree, in which 
case the homozygosity mapping approach will not yield the expected results [84]. In addition 
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to the detection of deleterious variants shared by affected individuals, the characterization of 
ROHs is utilized in population genetics. ROH's length decreases with genetic distance due to 
recombination events and thus may be used as an indication of recent or ancient inbreeding 
in the breed's population history. Genomic inbreeding coefficients estimated from ROHs have 
been shown to be more reliable and precise than pedigree-based coefficients, especially in 
case of incomplete, unreliable, or missing pedigree information [87]. 
Genome-wide association study (GWAS) 
In case-control studies, GWAS is the common method for identifying candidate genomic 
regions statistically associated with the studied trait or disease by comparison of allele 
frequency between unrelated affected and unaffected individuals. Most often this approach 
uses the SNP array genotyping data with thousands of polymorphic markers. Therefore, the 
SNP significantly associated with the investigated trait is not causative but considered to be in 
linkage disequilibrium with the true causal variant [88]. The results of GWAS are often 
displayed as a Manhattan plot with chromosome numbers on the X-axis and the negative 
logarithm of the association p-value for each SNP on the Y-axis (Figure 2) [89]. 
The power of GWAS to detect a true association depends on various factors, such as well-
defined phenotype, sample size, or data structure. Mode of inheritance determines the 
minimum number of cases and controls needed for the GWAS. About 10-20 dogs per group 
should be sufficient for mapping a simple recessive trait with high penetrance, while for a 
dominant trait at least 50 cases and 50 controls are needed. Much larger sample sizes are 
Figure 2. Illustration of GWAS used to detect disease-associated SNPs by comparison of two groups 
of dogs: cases (red) and controls (grey). The red line represents the Bonferroni correction level used to 
identify the genome-wide significantly associated SNPs (highlighted in green box). The Manhattan plot 
of GWAS in ARHGEF10-related polyneuropathy was reproduced with permission from [89]. 
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required for complex or polygenic traits [64]. Spurious associations might arise due to 
population stratification, family structure, and cryptic relatedness. These are commonly 
corrected for by the use of principal component analyses, multidimensional scaling methods, 
or mixed models including pair-wise genetic relationship matrices [90]. Additionally, the results 
have to be adjusted for multiple testing in order to avoid false-positive significant associations 
because of the thousands, potentially millions, of markers used. To set a meaningful 
significance threshold, Bonferroni correction, permutation testing, or false discovery rate 
methods are commonly implemented [88]. 
Whole-genome sequencing (WGS) 
Sequencing of an individual's whole genome has become affordable and the main genetic 
technique in human, as well as veterinary, precision medicine [19,91]. Since the development 
of the Sanger sequencing method (the first generation) in the 1970s, the technology for whole-
genome sequencing has evolved and been perfected in all aspects. Around the year 2000, the 
second-generation, also known as next-generation sequencing (NGS) methods emerged 
allowing the entire genome to be sequenced at once. Later around 2008, the third-generation 
sequencing methods further significantly improved the throughput, accuracy, time and cost 
efficiency of WGS [69]. A major challenge that these technologies bring is the production of a 
large amount of data that requires considerable computational resources and advanced 
bioinformatics tools for storage, handling, and downstream analyses [92]. 
The different NGS platforms vary in methodology, throughput, speed, and read lengths. 
Illumina's platform is the current leader in short-read sequencing using massively parallel 
sequencing by synthesis with optical base calling, which generates single or paired-end reads 
of ~150 bp on average. A major disadvantage of this technology is the inability to reliably 
resolve repetitive regions and detect larger structural variants in the genome. Long-read 
technologies, such as single-molecule real-time sequencing from Pacific Biosciences or 
nanopore sequencing from Oxford Nanopore Technologies, strive to overcome these 
challenges. Both platforms produce long to ultra-long reads (>1 kb to 2 Mb) enabling not only 
the analysis of structural variants but also high-quality de novo genome assemblies [93]. 
Although these techniques revolutionized genomic research and enabled the use of WGS for 
diagnostic purposes, Sanger sequencing is still used for targeted sequencing of candidate 
genes and validation of NGS output due to its highly accurate results of up to one kb long 




Discovery of private, shared, rare, or breed-specific variants 
Using the WGS data, it is possible to identify putative causal variants even without previous 
mapping strategies in cases where only a single or a limited number of affected animals are 
available. Short-read sequencing data may be analyzed to reveal a large portion of the genetic 
variation comprising single nucleotide variants (SNV) and small indels. The number of 
identified SNVs largely exceeds the number of genotyping array markers [20,94]. This 
extensive SNV dataset represents a part of an individual's normal variation. However, it may 
also contain the causative genetic variant underlying the inherited disease the individual 
suffers from. The pathogenic variants may be identified by comparing different individual 
datasets with each other. Especially for rare monogenic diseases, this approach is highly 
effective and has led to a rapid increase in the number of identified causative variants [94]. 
In order to find such variants, the reads obtained from WGS have to be filtered, deduplicated, 
and aligned to a reference genome sequence. Subsequently, the SNVs and small indels are 
called, filtered for quality, and annotated for prediction of each variant's impact on the protein 
level [95,96]. This approach is usually applied to a set of case and control animals and 
generates millions of variants across the genome. Therefore, hierarchical filtering strategies 
are used to reduce the number of variants. Figure 3 illustrates the most commonly used filtering 
options when using a large set of variants detected from WGS data. 
Usually, one or more cases (affected animals) are compared to controls, which may be 
represented either by known unaffected animals for the given phenotype or by population 
controls even with unknown health status of the same breed, or by all other genomes including 
different breeds (Figure 3A). In the case of rare and enriched variants, the alternative allele 
frequency in all genomes can be calculated to detect disease-associated variants that are 
Figure 3. Illustration of different strategies used when filtering variants detected from a large set of 
whole-genome sequences. Red- and grey-filled dogs represent cases and controls, respectively. The 
striped dogs represent control dogs that might also carry the variants. (A) Detection of private variants 
unique to the case or shared by multiple cases, and absent from controls. (B) Detection of rare or 
enriched variants present in one or more cases as well as a subset of controls. (C) Detection of breed-
specific variants present in all animals of one breed and absent from all other breeds. 
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potentially shared by several breed controls due to e.g. reduced penetrance or carrier status 
in recessive traits, or animals from other related breeds due to their shared history (Figure 3B). 
For detecting fixed breed-specific variants, all animals from one breed regardless of their 
phenotype are compared to all animals of various other breeds (Figure 3C). To further narrow 
down the list of trait-associated variants, filtering based on the mode of inheritance, especially 
in trio-based datasets, on a known list of candidate genes, in the region of interest from 
previous mapping approaches, or based on estimated functional impacts, is often performed. 
Estimation of functional impact remains challenging as genetic variants may have different 
effects from protein-changing variants altering gene function to non-coding variants with no 
clear impact. Apart from larger structural variants such as deletions of several Mb 
encompassing the entire gene, the SNVs easiest to detect and assess include start/stop codon 
alterations and frameshifts, followed by non-synonymous amino acid changes. However, the 
majority of the variant dataset consists of non-coding variants. The evaluation of the potential 
impact of synonymous or non-coding SNVs requires an advanced experimental setup [97]. 
In dogs, hundreds of whole genomes are already publically available and further efforts are 
underway to characterize and catalog the existing variation across canine populations, 
including ancient and modern dog breeds, village dogs, wolves, and other wild canids 
[20,98,99]. Despite the several described challenges, this kind of easily accessible resource 
makes the discovery of deleterious variants in rare canine neurogenetic diseases possible. 
Dog reference assembly 
In the mid-2000s, two consecutive assemblies were released (the initial CanFam1.0 and the 
CamFam2.0) and represented the first draft of the dog genome sequence published by the 
Dog Genome Sequencing Consortium at the Broad Institute [100] (Figure 4). This assembly 
spanned 2.41 Gb representing 99% of a female Boxer genome, but still contained many gaps, 
and was subsequently improved to the latest version CanFam3.1 [101]. Until recently, this 
genome build served as the annotated reference sequence for canine genomic studies, and is 
also used as such throughout my thesis. 
In the last years, new developments and better accessibility of NGS methods including long-
read technologies, together with ever-decreasing costs, resulted in superior and breed-specific 
de novo genome assemblies. Currently, five different breed reference sequences with 




This NCBI list includes an improved version of the original Boxer assembly 
(Dog10K_Boxer_Tasha, GCF_000002285.5) [103], and new assemblies from a Great Dane 
(UMICH_Zoey_3.1, GCF_005444595.1) [104], a German Shepherd (UU_Cfam_GSD_1.0, 
GCF_011100685.1) [105], a Basenji (UNSW_CanFamBas_1.0, GCF_013276365.1) [106], 
and a Labrador retriever (ROS_Cfam_1.0, GCF_014441545.1) [107] (Figure 4). 
The latest and still on-going development of multiple high-quality assemblies and annotations, 
representing distinct breeds (Figure 4) will enhance the accuracy of future genomic diversity 
and disease analyses. 
  
Figure 4. An overview of the development of canine annotated reference genomes over time 
highlighting the obvious breed differences. Photos adapted with permission from [100,104–107]. 
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Aim and hypothesis of the thesis 
The main aim of this thesis was to characterize the genetic etiology of rare forms of canine 
neurological diseases as potential models for similar human diseases. The general hypothesis 
assumed simple Mendelian inheritance and a breed-specific underlying variant. The results 
were expected to improve the health status of respective dog breeds by selective breeding 
against the unraveled deleterious variants, as well as to provide spontaneous animal models 
and possible new candidate genes for similar human inherited rare neurological disorders with 
yet unknown genetic causes. 
The following disorders were investigated in detail: 
1. peripheral polyneuropathy in Leonbergers, 
2. laryngeal paralysis and polyneuropathy in Leonbergers and Saint Bernards, 
3. inherited leukoencephalomyelopathy in Leonbergers and Rottweilers, 
4. neuroaxonal dystrophy in Rottweilers, 
5. spinocerebellar ataxia in a family of Alpine dachsbracke dogs, 
6. succinic semialdehyde dehydrogenase deficiency in Saluki dogs, 
7. Leigh-like subacute necrotizing encephalopathy in Yorkshire terriers. 
In the light of the extensive cohort of available samples and genomic data from purebred 
Leonbergers and their high prevalence of inherited diseases, an additional aim was to collect 
current phenotype information about the dogs in order to better define their health status to 
facilitate the identification of further disease-associated genomic regions. Therefore, an 
exhaustive genealogical and genomic description of this breed's current population and 
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Canine NAPEPLD-associated models of human myelin disorders 
 
 
Journal: Scientific Reports 
Manuscript status: published 
Contributions: Investigation, Formal analysis, Visualization, Writing – original 




 67   
 68   
 69   
 70   
 71   
 72   
 73   
 74   
 75   
 76   





A missense mutation in the vacuolar protein sorting 11 (VPS11) gene 
is associated with neuroaxonal dystrophy in Rottweiler dogs 
 
 
Journal: G3 Genes|Genomes|Genetics 
Manuscript status: published 




 81   
 82   
 83   
 84   
 85   
 86   
 87   
 88   
 
89 
A missense variant in SCN8A in Alpine dachsbracke dogs affected 




Manuscript status: published 
Contributions: Investigation, Formal analysis, Methodology, Visualization, 
Writing – original draft, Writing – review & editing 
 
 90 
 91   
 92   
 93   
 94   
 95   
 96   
 97   
 98 
 99   
 100   
 
101 
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Discussion and perspectives 
In this thesis, I investigated the molecular basis of seven different rare forms of canine 
neurological diseases as well as the population diversity and disease prevalence of one 
particular breed, the Leonberger. I was able to use different methods of genetic analysis and 
in all of these studies, compelling candidate genetic variants were successfully identified. The 
studied disorders represent a wide phenotypic spectrum of nervous system abnormalities and 
fall into different groups of neurogenetic diseases affecting various parts of the nervous system 
and diverse biological processes (Figure 5). 
The dramatic inbreeding situation in some dog populations often leads to breed-specific 
increased prevalence of inherited diseases. In the course of this thesis, I intensively studied 
the Leonberger breed as extensive genealogical, SNP array, as well as WGS data was 
available for more than 140,000, 1,200, and 39 dogs, respectively. In similar studies of within-
breed diversity performed for different breeds, comparably smaller SNP array datasets have 
been previously explored, e.g. 34 German shorthaired pointers [108], 48 Braque Français 
[109], 188 Bullmastiff dogs [110], or 255 Border collies [111]. Also WGS data of a limited 
number of dogs, e.g. 15 Standard poodles [112] or 6 Norwegian lundehund dogs [113], have 
been used before to characterize the ROH and explore fixed or enriched variants present in 
the breeds. My study of the Leonberger breed provided the first comprehensive 
characterization of the worldwide population and confirmed the assumed reduced genetic 
diversity after a historical bottleneck, as well as recent inbreeding despite the ever-growing 
Figure 5. Simplified representation of the investigated canine neurological diseases showing the 
different parts of the nervous system they primarily affect, including the genes harboring the identified 
variants associated with each disorder (in red). 
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number of dogs. Analysis of pedigree and medical records of thousands of purebred 
Leonbergers revealed a serious popular sire effect, high relatedness among the dogs, a slow 
continuous decrease of average life expectancy across time (from 9.4 years in 1989 to 7.7 
years in 2004), and a high prevalence of various forms of cancer, orthopedic, and neurological 
disorders. Using SNP array data I found no obvious subpopulations in the dataset collected 
worldwide from 28 countries, and investigated the ROH to estimate the average genomic 
inbreeding coefficient (FROH) of 0.28. This was expected in an inbred modern dog breed and 
falls within the range reported in breeds, such as Rottweiler (FROH=0.29), German shepherd 
(FROH=0.31), or Bernese mountain dog (FROH=0.30) [114]. However, many breeds show 
comparably lower values, such as Czechoslovakian wolfdog (FROH=0.17) [115], Braque 
Français (FROH=0.18), Poodle (FROH=0.18), Border collie (FROH=0.15), or Jack Russell terrier 
(FROH=0.08) [114]. On the other hand, the Norwegian lundehund breed that is highly inbred 
and known to be at risk for a breed-specific multifactorial life-threatening syndrome has an 
inbreeding coefficient as high as 0.87 [116]. Furthermore, the WGS data provided evidence for 
breed-specific non-coding variants as well as private (unique to Leonbergers) and enriched 
(rarely seen in other breeds) potentially pathogenic variants in 38 Leonbergers affected by 
neurological disease. In addition, only two haplotypes were detected in their mitochondrial 
genomes. The overall high relatedness underlines the elevated risk for the occurrence of 
recessive Mendelian diseases. On the other hand, fixation or enrichment of many 
uncharacterized alleles in various genes due to the excessive usage of a few popular sires 
might explain the overall general predisposition towards more complex neurological disorders 
[117]. Besides the technical limitations of using only short-read sequencing methods, late-
onset forms of disorders, and possible complex underlying genetics complicate the discovery 
of disease-associated variants and illustrate the limitation of current genomic approaches. In 
the light of the low diversity and always new emerging diseases in the Leonberger breed, 
outcrossing might be a prospective solution to increase heterozygosity and improve the overall 
health and well-being of the dogs in the long term. It has to be, however, performed 
continuously and ideally complemented with changes in population structure and breeding 
organization to have a lasting effect [118]. 
Studies of inherited neuropathies are challenging due to their complexity and heterogeneity of 
clinicopathological signs, as well as other features such as varying age of onset. I described 
two novel forms of canine polyneuropathy and/or laryngeal paralysis (LPPN) during this thesis. 
The affected dogs showed diverse phenotypes of clinical signs and severity. As known from 
human medicine, the nomenclature of CMT forms is complicated and has been regularly 
revised due to the continuous identification of new genetic causes [21]. In dogs, the situation 
is comparably complicated and a classification based solely on clinicopathological 
observations is usually not precise enough [26,31]. The success of finding the causal variant 
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by genomic analysis is dependent on the available sample size, especially in the presence of 
significant disease heterogeneity. In two studies of canine forms of polyneuropathy, different 
strategies of GWAS combined with WGS were applied. First, we assumed a breed-specific 
variant for an adult-onset form of polyneuropathy observed in Leonbergers. Using SNP array 
genotypes of more than 200 cases and controls we fine-mapped the associated ~7.7 Mb-sized 
genomic region in which private case-specific variants were then filtered in WGS data. This 
approach revealed a private homozygous 2 bp deletion leading to a frameshift in the GJA9 
gene encoding a connexin protein involved in the formation of gap junctions. This likely 
pathogenic small indel was present in about a quarter of the studied cases illustrating the 
challenge of genetic heterogeneity. Following segregation analysis by genotyping thousands 
of Leonbergers suggested a dominant mode of inheritance with incomplete penetrance as 
some heterozygous dogs did not show any clinical signs at the age of 8 years. Other gap 
junction proteins have been associated with diverse nervous system disorders in humans, 
including a form of CMT [119,120]. Thus, our study adds GJA9 for the first time to the list of 
candidate genes for human neuropathy patients with unsolved etiology. 
In the subsequently performed study aiming to detect the causes of further forms of LPPN, I 
found an autosomal recessive missense variant in the CNTNAP1 gene in two closely related 
dog breeds, the Leonberger and Saint Bernard, showing early signs of laryngeal paralysis as 
the main disease sign. Using strict inclusion criteria for the cases and controls, across-breed 
GWAS with imputed SNP array data of more than 500 dogs was successful in mapping the 
disease-associated genomic region to about 1 Mb. Exploring this region in the WGS data of 5 
cases from both breeds for shared variants identified a single protein-changing missense 
variant in the CNTNAP1 gene. CNTNAP1 encodes a contactin-associated protein important 
for the organization of myelinated axons and variants in this gene have been previously 
implicated in human childhood-onset CMT, and hypomyelinating neuropathy, including vocal 
cord palsy and severe respiratory distress [121,122]. The canine LPPN form seems therefore 
clinically equivalent to the human disease. Only 4% of the analyzed affected Leonbergers and 
42% of Saint Bernards were homozygous mutant for this variant illustrating once more the 
challenge of large genetic heterogeneity of different forms of canine LPPN. Interestingly, when 
searching the Dog biomedical variant database [20] of >700 publicly available dogs of 131 
different breeds and wolves, I found the CNTNAP1 variant in several other unrelated dog 
breeds, indicating it likely predates modern breed establishment. Using targeted genotyping 
by Sanger sequencing of almost 5,000 animals, the variant occurred in 25 different dog breeds 
with mostly unknown precise health history. However, we were able to evaluate available 
LPPN phenotypes in one breed, the Labrador retriever, where homozygosity for the described 
variant explained a portion of cases with a younger age of onset. Whether this variant is 
disease-causing also in smaller dog breeds segregating for this variant needs to be evaluated 
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in the future when detailed disease phenotypes are available. Furthermore, the breed 
differences might be due to different genetic background and/or differences in size and 
correspondingly shorter laryngeal nerves. Such relationship was previously suggested by 
correlation between height and laryngeal neuropathy in horses [123]. 
Leukoencephalomyelopathy (LEMP) in Leonberger and Rottweiler dogs is classified as a 
myelin disorder. I used similar methodological approaches in this study of a limited number of 
affected dogs from the two breeds as in the previously described polyneuropathies. Within-
breed GWAS was performed and subsequent WGS and targeted genotyping by Sanger 
sequencing revealed a private deleterious variant in the same gene in each breed. Both 
variants, a missense and a frameshift, occurred in the NAPEPLD gene encoding an enzyme 
of the endocannabinoid system showing evidence for obvious allelic heterogeneity of this 
disorder in dogs. Similar heterogeneity was previously found e.g. in RAB3GAP1-related 
polyneuropathy that is associated with a large insertion in Alaskan husky [124], and a 
frameshift variant in Black Russian terrier and Rottweiler [125] (OMIA 001970-9615). The first 
description of NAPEPLD-associated inherited defects in the endocannabinoid system might 
be important for future investigation of myelin disorders, as the neuromodulatory system has 
important functions in central nervous system development, synaptic plasticity, and the 
response to endogenous and environmental insults [126]. Interestingly, when screening other 
related breeds for the NAPEPLD frameshift variant, I found it was present heterozygously in 
several unaffected Great Danes indicating an older origin of this mutation compared to the 
missense variant found in Leonbergers. However, until now no homozygous mutant dog was 
seen in this third breed. The identification of different independently occurring variants in the 
same gene and diverse dog breeds affected by one disease with heterogeneous pathological 
features implicates the NAPEPLD enzyme as important in myelin homeostasis. Therefore, this 
study provides NAPEPLD as a new functional candidate gene for LEMP, a canine model for 
the corresponding human myelin disorders, to establish molecular diagnosis and potential pre-
clinical trials in dogs, and highlights dog as a model to study the functions and molecular 
pathology of the NAPEPLD gene. 
Another herein described disease is the neuroaxonal dystrophy seen in young Rottweilers, 
which has clinicopathological features in common with the human neuroaxonal dystrophy. 
DNA samples from seven affected and almost 300 normal Rottweilers were available. 
Interestingly, three of the cases examined during the study were not closely related, while the 
other four were halfsiblings born around 1980 [127]. This suggested a relatively older mutation 
event and silent transmission of the recessive disease-causing allele through many 
generations. Therefore, homozygosity mapping was performed to narrow down the associated 
genomic region detected by GWAS. By WGS of two cases and comparison of their data with 
~100 controls of 25 different breeds, only a single case-specific homozygous protein-changing 
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variant in the VPS11 gene was found. Further targeted genotyping of more than 400 dogs from 
20 breeds confirmed the suspected breed-specificity of the VPS11 missense variant and an 
estimated allele frequency of ~2% in the Rottweiler population. VPS11 encodes a protein with 
a known function in vesicle transport to vacuoles and an essential role in the endosomal-
autophagy-lysosomal pathways [128]. In humans, VPS11 mutations are associated with an 
infantile-onset neurological syndrome characterized as hypomyelinating leukodystrophy and 
lysosomal storage disease [129]. The human and canine phenotypes have distinct differences, 
clearly pointing out the spectrum of phenotypic heterogeneity caused by variants within the 
same gene disrupting an important biological system. Therefore, VPS11 represents a potential 
candidate for unexplained forms of human neuroaxonal dystrophy patients. 
Spinocerebellar ataxia in Alpine dachsbracke dogs is an example of a simple monogenic 
recessive disease. Four puppies from two litters showed signs of cerebellar dysfunction, while 
all parents of the affected dogs were phenotypically normal. By pedigree analysis of the two 
ataxia-affected litters, I revealed an obvious recent inbreeding loop. Although only a very 
limited number of cases and their relatives was available, the outcome of the genetic analyses 
was unambiguous. Assuming the recessive mode of inheritance, homozygosity and linkage 
analyses were performed to map the ~5.5 Mb-sized disease-associated locus, followed by 
WGS filtering for homozygous SNVs unique to the sequenced case. This led to the 
identification of a single non-synonymous variant in the SCN8A gene, which segregated 
perfectly with the phenotype in the pedigree; after further targeted genotyping of ~200 
unrelated Alpine dachsbracke dogs, the variant occurred homozygously only in the original 
four studied cases. SCN8A encodes a voltage-gated sodium channel [130] and variants in this 
gene were previously reported in human patients exhibiting ataxia, cerebellar atrophy, 
cognitive disability, as well as early-onset epileptic encephalopathies [131,132]. The developed 
DNA test enables informed breeding decisions and provides an important tool in the precise 
diagnosis of canine ataxia as it is a relatively non-specific condition. 
Finally, I investigated two canine neurometabolic disorders, namely succinic semialdehyde 
dehydrogenase deficiency (SSADHD) in Saluki dogs and subacute necrotizing 
encephalopathy in Yorkshire terriers. Even though both diseases fall into the same category 
of inborn errors of metabolism, they represent very different clinicopathological phenotypes, 
also reflected in the diverse underlying genetics. Consequently, different samples were 
available, and various methods for genomic analysis were used. In the SSADHD-affected 
Saluki dogs, independent studies were initially conducted in Europe and the USA in different 
Saluki litters showing the identical rare disease phenotype. Through international collaboration 
the available data was then combined, strengthening the power of detection of the disease-
associated variant. All seven cases had striking similarities to SSADHD in humans, although 
the canine phenotype was more severe. By in-depth pedigree analysis, I showed the presence 
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of a common male ancestor connecting the American and European dog families and 
suspected an autosomal recessive mode of inheritance. GWAS with only a limited number of 
dogs and subsequent filtering of WGS data of cases from geographically different locations 
revealed a breed-specific missense variant in the ALDH5A1 gene. This gene encodes a 
mitochondrial enzyme SSADH involved in the catabolism of major inhibitory neurotransmitter 
in the CNS [133]. Disruption of this metabolic pathway leads to an accumulation of potentially 
toxic metabolites in brain, and was previously described in human neurological disease with 
wide phenotypic heterogeneity [134]. Elevated levels of such metabolites were also detected 
in the Saluki cases and can be used as biomarkers in urine or serum for canine SSADHD. As 
there is no effective treatment, the dog provides a potential model for evaluation of therapeutic 
approaches that have so far not been tested in SSADHD, such as pharmacological treatment 
by targeting neurotransmitter receptors, enzyme-replacement therapy, or gene therapy. This 
large-animal model could be especially important because of early lethality in the existing 
Aldh5a−/− knockout mouse model, which makes any treatment trials problematic [135]. 
The second metabolic disorder occurred in ten mostly unrelated Yorkshire terriers that were 
diagnosed with subacute necrotizing encephalopathy (SNE) according to the previous 
neuropathological description of the condition, which closely resembled a form of SNE in a 
different dog breed [136] as well as Leigh syndrome (LS) in humans [137]. Human LS is an 
early-onset, often fatal progressive mitochondrial respiratory chain disease affecting the CNS 
with considerable genetic heterogeneity. Apart from the mutations of respiratory chain protein 
complexes, a biochemical defect in thiamine metabolism was also suggested in LS. 
Pathogenic variants in over 60 different genes of the mitochondrial or nuclear genome still do 
not explain all described human cases [138]. In the previous study of SNE in Yorkshire terriers, 
Baiker et al. used targeted sequencing and Southern blot analysis to exclude mitochondrial 
tRNA mutations and large genetic rearrangements as the possible underlying cause [137]. In 
our study, I used homozygosity analysis combined with WGS comparison of the SNE-affected 
dog with 60 unrelated Yorkshire terriers and more than 600 other breed controls to identify a 
small structural variant in SLC19A3 gene. Sanger sequencing of the variant confirmed its 
homozygous presence in all SNE-affected dogs and revealed the detailed features of this indel 
that affects ~45 nucleotides and disturbs the reading frame. Notably, the initial automatic 
variant calling reported a simple 8 bp deletion highlighting the need for experimental validation 
of the WGS output in the lab. The SLC19A3 gene encodes a thiamine transporter 2 important 
in brain development. Its disruption by homozygous or compound heterozygous variants was 
previously seen in human thiamine metabolism dysfunction syndrome, also known as 
thiamine-responsive encephalopathy [139,140]. A different small indel in the same gene was 
also reported in Alaskan huskies with SNE [141]. The identification of a second, independent 
variant in Yorkshire terriers, therefore, adds evidence to the causal relationship between 
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SLC19A3 and this form of neurometabolic disorder. The availability of naturally occurring dogs 
with a Leigh-like disease may provide a feasible approach for an investigation of mitochondrial 
disease mechanisms, and serve as a model for further comparative and translational research. 
In summary, the eight developed DNA tests (Table 6) provide breeders a tool to improve 
animal health and welfare. Although directly eliminating all carriers from the breeds would 
quickly decrease the mutant allele frequency, it might have negative consequences on genetic 
diversity of the closed populations. Therefore, genetic testing of breeding dogs to avoid carrier 
matings and slowly decreasing the allele frequency is usually recommended [117]. This 
strategy has been successfully adopted in recent years as shown by the decline in the number 
of affected dogs as well as the disease-associated variant frequencies within several breeds 
following the commercial availability of DNA tests [142]. Notably, the various sizes of the 
mapped critical regions together with the variant occurrence in other breeds support the 
different assumptions about the age of mutation events, as e.g. the CNTNAP1-associated 
region was almost eight times shorter compared to the GJA9 haplotype. Furthermore, recent 
inbreeding loops result in relatively larger associated regions as seen in the ataxia-affected 
Alpine dachsbracke dogs as opposed to a probably older and more widespread variants in the 
SNE-affected Yorkshire terriers or SSADHD-affected Saluki dogs (Table 6). 
Table 6. A list of likely causative variants in the seven investigated phenotypes showing the size of 
mapped associated genomic regions, the total number of genotyped dogs in each study, and the 
estimated variant allele frequencies in the respective cohorts of genotyped dogs. 
Breed MOI1 Critical region (Mb) 
Associated 
gene Variant
2 Genotyped dogs 
Variant allele 
frequency (%) 
Polyneuropathy and/or laryngeal paralysis 






























Rottweiler AR 4.46 VPS11 MS 288 4.7 
Spinocerebellar ataxia 
Alpine dachsbracke AR 5.53 SCN8A MS 285 4.9 
Neurometabolic disorder 
Saluki AR 2.68 ALDH5A1 MS 72 21.5 
Yorkshire terrier AR 1.71 SLC19A3 FS 232 5.0 
1 MOI = mode of inheritance as follows: AR = autosomal recessive, AD = autosomal dominant. 
2 Type of variant as follows: MS = missense, FS = frameshift. Multiple entries correspond to different 




In theory, access to a single affected animal is sufficient to find the genetic cause of a simple 
recessive condition if a candidate gene is affected by a variant that is detectable by standard 
bioinformatics pipeline (i.e. SNV or small indel), and has a relatively easily predictable effect 
on the encoded protein. Many more related and unrelated case and control animals are needed 
for genetic analysis in situations of complex phenotypes with more complicated modes of 
inheritance, presence of phenocopies, and large structural, silent, or non-coding variants with 
difficult effect predictions. For example, a synonymous variant in an exon of the bovine MFN2 
gene has been perfectly associated with degenerative axonopathy in Tyrolean grey cattle 
[143]. The impact of such variant was unclear until further transcript analysis by Northern blot 
and RT-PCR was performed, which revealed partial intron retention leading to a premature 
stop codon [143]. Furthermore, the effect and impact prediction of non-coding variants has 
become one of the main challenges of the NGS era. To correctly interpret and finally prove the 
causality of an identified variant, several conditions should be met [144,145]. With appropriate 
sample sizes and properly described phenotypes, sufficient proof of causality is usually 
achieved with genomic data for highly penetrant variants following Mendelian inheritance. In 
complex traits, robust evidence of pathogenicity is more challenging and often requires 
additional functional validation studies with sophisticated tools such as expression studies in 
different model systems, or CRISPR/Cas9 gene editing [146]. For example, successful 
preservation of myelin was previously shown in a mouse model of the PMP22-associated form 
of CMT after targeted editing by CRISPR/Cas9, and the approach partially rescued the axonal 
demyelination even after the onset of disease [147].  
Due to the small number of human patients with rare neurogenetic diseases, and the large lists 
of variants identified from WGS, it might be difficult to pinpoint the pathogenic variant. Thus, 
the availability of clinically relevant, reproducible, and representative animal models is crucial 
[148]. Naturally occurring inherited disorders in companion animals, such as dogs and cats, 
are often orthologous to those found in humans and, in comparison with mouse models, 
provide a more relevant large-animal system enabling the development of e.g. accurate 
biodistribution studies due to increased brain and body size, or long-term efficacy and safety 
studies due to longer lifespan [148]. Several dog models of inherited musculoskeletal and 
neurodegenerative disorders, such as various myelin disorders or neurometabolic diseases, 
have been already described and proven invaluable for developing therapies for humans as 
well as for dogs in the frame of precision medicine [44]. The usefulness of naturally occurring 
canine models is evident from many examples, such as enzyme replacement therapy and 
adeno-associated viral gene therapy tested in the Dachshund model of CLN2-related NCL 
[149,150]. Both treatment studies showed a delay in the onset of neurological deficits and an 
increased lifespan in the dogs, and led to the initiation of human clinical trials [149,150]. 
Globoid cell leukodystrophy (GLD) is an example of myelin disorder affecting both the CNS 
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and PNS that often results in early death. As the current and only available treatment is 
hematopoietic stem cell transplantation in pre-symptomatic patients, the evaluation of different 
approaches in canine pre-clinical trials is important [44]. Bradbury et al. showed that adeno-
associated viral gene therapy in the naturally occurring canine model of GALC-associated GLD 
improved myelination in both the CNS and PNS, delayed the onset of clinical signs, and 
doubled the lifespan of GLD-affected dogs. These results may offer dramatic improvements 
for treatment of human patients [151]. The herein described spontaneous canine models of 
neurometabolic disorders related to SLC19A3 and ALDH5A1 defects may serve similarly in 
the future. 
Furthermore, the assignment of novel functions to disease-associated genes in dog studies 
leads to new functional candidates for similar human conditions. Previously, for example, 
SERPINH1-related osteogenesis imperfecta in Dachshunds [66] or ASPRV1-related skin 
disorder in German shepherds [152] have been characterized before the first variants in these 
genes were discovered in human patients with unexplained forms of the corresponding 
disorders [153,154], and thus provided additional evidence to the causal relationship. The 
herein described association of GJA9 with neuropathy or NAPEPLD with myelin disorders 
provides a basis for such discoveries in human patients. 
In conclusion, this thesis shows the great potential of WGS-based precision diagnosis in 
veterinary medicine using large datasets produced with affordable NGS techniques and thus 
confirms numerous similar reports in companion animals [91,155–157]. The typical structure 
of dog populations allows for efficient use of high-density SNP array data in various genetic 
mapping methods. With a combination of these approaches, I described the genetic etiology 
of seven canine forms of rare inherited neurological diseases. My results provide an immediate 
translation into breeding practice as genetic tests are adopted by breeders of the respective 
dog populations to avoid producing affected dogs and eradicate the described conditions. 
Beyond aspects of dog breeding and veterinary medicine, the disease association of 
pathogenic variants in genes that are not yet known to be involved in corresponding human 
genetic disorders provides valuable insights into the molecular mechanisms and biological 
functions, and contributes novel candidate genes for human patients with unsolved genetic 
etiology. Further research into different forms of canine neurological diseases, with an in-depth 
description of the pathology, may help the development of therapeutic interventions benefiting 




~Discovery is easy. Understanding is the hard part.~ 
This thesis was carried out at the Institute of Genetics at the University of Bern under the 
supervision of Cord Drögemüller. I am very grateful to Cord for welcoming me to the group 
briefly for my master thesis research, and later inviting me back to Bern, and giving me the 
opportunity to continue pursuing my interest in animal genetics during this massive PhD 
project. It has been a long journey with a steep learning curve, but in all respects very much 
worthwhile. Thank you for both professional and personal support and advice. 
All this work would not be possible without the help and support of Katie Minor and Jim 
Mickelson from the Canine Genetics Lab at the University of Minnesota. Thank you Katie and 
Mick for always being there to discuss, suggest, edit, proofread, motivate, and so much more. 
A big thank you goes to Nathalie Besuchet-Schmutz in our lab for the tremendous help with 
genotyping and always knowing where everything is. Equally big thank you to Vidhya 
Jagannathan behind the computer for showing me the magic of bioinformatics and always 
being helpful even with a full table of work to do. 
I would like to thank the whole genetics team for creating the best working environment one 
could ever wish for. Thank you to Tosso Leeb for friendly discussions, always new challenges, 
and overall support. Furthermore, this includes all the past and present group members, thanks 
to fellow PhD students for fun discussions about common problems, all doctoral students for 
providing essential veterinary advice, master students for allowing me to develop my mentoring 
skills, as well as the secretaries for always knowing the answer when filling out difficult forms. 
Thank you to my thesis committee, Rémy Bruggmann for being my co-supervisor, André 
Schaller for being my mentor, and Göran Andersson for agreeing to act as my external co-
referee. 
Thank you to all dog owners, breeders, breeder clubs, and unions, as well as veterinarians for 
sending us samples, pedigrees, and health reports about their dogs, without this valuable 
information and continuing support there would be no project. I would also like to acknowledge 
all other collaborators in the different research projects. It is a pleasure to work together with 
great scientists from around the world. 
My warmest thank you to my family for the enormous support during this journey and a very 
special thank you to Ivan Letko, my husband, cook, manager, illustrator, fellow gamer, 




Removed due to data privacy reasons.  
 
144 
List of publications 
Published articles 
Letko, A.; Schauer A.M.; Derks M.F.L.; Grau-Roma L.; Drögemüller, C.; Grahofer A. 
Phenotypic and Genomic Analysis of Cystic Hygroma in Pigs. Genes (Basel). 2021, 12, 207, 
doi:10.3390/genes12020207. 
Letko, A.; Minor, K.M.; Friedenberg, S.G.; Shelton, G.D.; Salvador, J.P.; Mandigers, P.J.J.; 
Leegwater, P.A.J.; Winkler, P.A.; Petersen-Jones, S.M.; Stanley, B.J.; Ekenstedt, K.J.; 
Johnson, G.S.; Hansen, L.; Jagannathan, V.; Mickelson, J.R.; Drögemüller, C. A CNTNAP1 
Missense Variant Is Associated with Canine Laryngeal Paralysis and Polyneuropathy. Genes 
(Basel). 2020, 11, 1426, doi:10.3390/genes11121426. 
Letko, A.; Strugnell, B.; Häfliger, I.M.; Paris, J.M.; Waine, K.; Drögemüller, C.; Scholes, S. 
Compound heterozygous PLA2G6 loss-of-function variants in Swaledale sheep with 
neuroaxonal dystrophy. Mol. Genet. Genom. 2020, doi:10.1007/s00438-020-01742-1. 
Jacinto, J.G.P.; Häfliger, I.M.; Veiga, I.M.B.; Letko, A.; Benazzi, C.; Bolcato, M.; Drögemüller, 
C. A Heterozygous Missense Variant in the COL5A2 in Holstein Cattle Resembling the 
Classical Ehlers–Danlos Syndrome. Animals (Basel). 2020, 10, 2002, 
doi:10.3390/ani10112002. 
Drögemüller, M.; Letko, A.; Matiasek, K.; Jagannathan, V.; Corlazzoli, D.; Rosati, M.; Jurina, 
K.; Medl, S.; Gödde, T.; Rupp, S.; Fischer, A.; Luján Feliu-Pascual, A.; Drögemüller, C. 
SLC19A3 Loss-of-Function Variant in Yorkshire Terriers with Leigh-Like Subacute Necrotizing 
Encephalopathy. Genes (Basel). 2020, 11, 1215, doi:10.3390/genes11101215. 
Letko, A.; Minor, K.M.; Jagannathan, V.; Seefried, F.R.; Mickelson, J.R.; Oliehoek, P.; 
Drögemüller, C. Genomic diversity and population structure of the Leonberger dog breed. 
Genet. Sel. Evol. 2020, 52, 61, doi:10.1186/s12711-020-00581-3. 
Brunetti, B.; Muscatello, L. V.; Letko, A.; Papa, V.; Cenacchi, G.; Grillini, M.; Murgiano, L.; 
Jagannathan, V.; Drögemüller, C. X-Linked Duchenne-Type Muscular Dystrophy in Jack 
Russell Terrier Associated with a Partial Deletion of the Canine DMD Gene. Genes (Basel). 
2020, 11, 1175, doi:10.3390/genes11101175. 
Letko, A.; Dijkman, R.; Strugnell, B.; Häfliger, I.M.; Paris, J.M.; Henderson, K.; Geraghty, T.; 
Orr, H.; Scholes, S.; Drögemüller, C. Deleterious AGXT Missense Variant Associated with 
Type 1 Primary Hyperoxaluria (PH1) in Zwartbles Sheep. Genes (Basel). 2020, 11, 1147, 
doi:10.3390/genes11101147. 
Jacinto, J.G.P.; Häfliger, I.M.; Letko, A.; Drögemüller, C.; Agerholm, J.S. A large deletion in 
the COL2A1 gene expands the spectrum of pathogenic variants causing bulldog calf syndrome 
in cattle. Acta Vet. Scand. 2020, 62, 49, doi:10.1186/s13028-020-00548-w. 
Vernau, K.M.; Struys, E.; Letko, A.; Woolard, K.D.; Aguilar, M.; Brown, E.A.; Cissell, D.D.; 
Dickinson, P.J.; Shelton, G.D.; Broome, M.R.; Gibson, K.M.; Pearl, P.L.; König, F.; Van Winkle, 
T.J.; O’Brien, D.; Roos, B.; Matiasek, K.; Jagannathan, V.; Drögemüller, C.; Mansour, T.A.; 
Brown, C.T.; Bannasch, D.L. A Missense Variant in ALDH5A1 Associated with Canine Succinic 
Semialdehyde Dehydrogenase Deficiency (SSADHD) in the Saluki Dog. Genes (Basel). 2020, 
11, 1033, doi:10.3390/genes11091033. 
Paris, J.M.; Letko, A.; Häfliger, I.M.; Ammann, P.; Drögemüller, C. Ear type in sheep is 
associated with the MSRB3 locus. Anim. Genet. 2020, 51, 968–972, doi:10.1111/age.12994. 
Batcher, K.; Dickinson, P.; Maciejczyk, K.; Brzeski, K.; Rasouliha, S.H.; Letko, A.; 
Drögemüller, C.; Leeb, T.; Bannasch, D. Multiple FGF4 Retrocopies Recently Derived within 
Canids. Genes (Basel). 2020, 11, 839, doi:10.3390/genes11080839. 
Häfliger, I.M.; Letko, A.; Murgiano, L.; Drögemüller, C. De novo stop‐lost germline mutation in 
FGFR3 causes severe chondrodysplasia in the progeny of a Holstein bull. Anim. Genet. 2020, 
 
145 
51, 466–469, doi:10.1111/age.12934. 
Simon, R.; Lischer, H.E.L.; Pieńkowska‐Schelling, A.; Keller, I.; Häfliger, I.M.; Letko, A.; 
Schelling, C.; Lühken, G.; Drögemüller, C. New genomic features of the polled intersex 
syndrome variant in goats unraveled by long‐read whole‐genome sequencing. Anim. Genet. 
2020, 51, 439–448, doi:10.1111/age.12918. 
Letko, A.; Leuthard, F.; Jagannathan, V.; Corlazzoli, D.; Matiasek, K.; Schweizer, D.; Hytönen, 
M.K.; Lohi, H.; Leeb, T.; Drögemüller, C. Whole Genome Sequencing Indicates Heterogeneity 
of Hyperostotic Disorders in Dogs. Genes (Basel). 2020, 11, 163, 
doi:10.3390/genes11020163. 
Leeb, T.; Leuthard, F.; Jagannathan, V.; Kiener, S.; Letko, A.; Roosje, P.; Welle, M.M.; 
Gailbreath, K.L.; Cannon, A.; Linek, M.; Banovic, F.; Olivry, T.; White, S.D.; Batcher, K.; 
Bannasch, D.; Minor, K.M.; Mickelson, J.R.; Hytönen, M.K.; Lohi, H.; Mauldin, E.A.; Casal, M.L. 
A Missense Variant Affecting the C-Terminal Tail of UNC93B1 in Dogs with Exfoliative 
Cutaneous Lupus Erythematosus (ECLE). Genes (Basel). 2020, 11, 159, 
doi:10.3390/genes11020159. 
Paris, J.M.; Letko, A.; Häfliger, I.M.; Švara, T.; Gombač, M.; Klinc, P.; Škibin, A.; Pogorevc, 
E.; Drögemüller, C. A de novo variant in OTX2 in a lamb with otocephaly. Acta Vet. Scand. 
2020, 62, 5, doi:10.1186/s13028-020-0503-z. 
Hirter, N.; Letko, A.; Häfliger, I.M.; Becker, D.; Greber, D.; Drögemüller, C. A genome‐wide 
significant association on chromosome 15 for congenital entropion in Swiss White Alpine 
sheep. Anim. Genet. 2020, 51, 278–283, doi:10.1111/age.12903. 
Letko, A.; Ammann, B.; Jagannathan, V.; Henkel, J.; Leuthard, F.; Schelling, C.; Carneiro, M.; 
Drögemüller, C.; Leeb, T. A deletion spanning the promoter and first exon of the hair cycle‐
specific ASIP transcript isoform in black and tan rabbits. Anim. Genet. 2020, 51, 137–140, 
doi:10.1111/age.12881. 
Paris, J.M.; Letko, A.; Häfliger, I.M.; Ammann, P.; Flury, C.; Drögemüller, C. Identification of 
two TYRP1 loss-of-function alleles in Valais Red sheep. Anim. Genet. 2019, 50, 778–782, 
doi:10.1111/age.12863. 
Letko, A.; Zdora, I.; Hitzler, V.; Jagannathan, V.; Beineke, A.; Möhrke, C.; Drögemüller, C. A 
de novo in‐frame duplication in the COL1A2 gene in a Lagotto Romagnolo dog with 
osteogenesis imperfecta. Anim. Genet. 2019, 50, 786–787, doi:10.1111/age.12843. 
Küttel, L.; Letko, A.; Häfliger, I.M.; Signer‐Hasler, H.; Joller, S.; Hirsbrunner, G.; Mészáros, G.; 
Sölkner, J.; Flury, C.; Leeb, T.; Drögemüller, C. A complex structural variant at the KIT locus 
in cattle with the Pinzgauer spotting pattern. Anim. Genet. 2019, 50, 423–429, 
doi:10.1111/age.12821. 
Hédan, B.; Cadieu, E.; Botherel, N.; Dufaure de Citres, C.; Letko, A.; Rimbault, M.; 
Drögemüller, C.; Jagannathan, V.; Derrien, T.; Schmutz, S.; Leeb, T.; André, C. Identification 
of a Missense Variant in MFSD12 Involved in Dilution of Phaeomelanin Leading to White or 
Cream Coat Color in Dogs. Genes (Basel). 2019, 10, 386, doi:10.3390/genes10050386. 
Letko, A.; Dietschi, E.; Nieburg, M.; Jagannathan, V.; Gurtner, C.; Oevermann, A.; 
Drögemüller, C. A Missense Variant in SCN8A in Alpine Dachsbracke Dogs Affected by 
Spinocerebellar Ataxia. Genes (Basel). 2019, 10, 362, doi:10.3390/genes10050362. 
Grahofer, A.; Letko, A.; Häfliger, I.M.; Jagannathan, V.; Ducos, A.; Richard, O.; Peter, V.; 
Nathues, H.; Drögemüller, C. Chromosomal imbalance in pigs showing a syndromic form of 
cleft palate. BMC Genomics 2019, 20, 349, doi:10.1186/s12864-019-5711-4. 
Lucot, K.L.; Dickinson, P.J.; Finno, C.J.; Mansour, T.A.; Letko, A.; Minor, K.M.; Mickelson, 
J.R.; Drögemüller, C.; Brown, C.T.; Bannasch, D.L. A Missense Mutation in the Vacuolar 
Protein Sorting 11 (VPS11) Gene Is Associated with Neuroaxonal Dystrophy in Rottweiler 
Dogs. G3 (Bethesda) 2018, 8, 2773–2780, doi:10.1534/g3.118.200376. 
 
146 
Dürig, N.; Letko, A.; Lepori, V.; Hadji Rasouliha, S.; Loechel, R.; Kehl, A.; Hytönen, M.K.; Lohi, 
H.; Mauri, N.; Dietrich, J.; Wiedmer, M.; Drögemüller, M.; Jagannathan, V.; Schmutz, S.M.; 
Leeb, T. Two MC1R loss-of-function alleles in cream-coloured Australian Cattle Dogs and 
white Huskies. Anim. Genet. 2018, 49, 284–290, doi:10.1111/age.12660. 
Minor, K.M.; Letko, A.; Becker, D.; Drögemüller, M.; Mandigers, P.J.J.; Bellekom, S.R.; 
Leegwater, P.A.J.; Stassen, Q.E.M.; Putschbach, K.; Fischer, A.; Flegel, T.; Matiasek, K.; 
Ekenstedt, K.J.; Furrow, E.; Patterson, E.E.; Platt, S.R.; Kelly, P.A.; Cassidy, J.P.; Shelton, 
G.D.; Lucot, K.; Bannasch, D.L.; Martineau, H.; Muir, C.F.; Priestnall, S.L.; Henke, D.; 
Oevermann, A.; Jagannathan, V.; Mickelson, J.R.; Drögemüller, C. Canine NAPEPLD-
associated models of human myelin disorders. Sci. Rep. 2018, 8, 5818, doi:10.1038/s41598-
018-23938-7. 
Letko, A.; Drögemüller, C. Two brown coat colour-associated TYRP1 variants (bc and bd) 
occur in Leonberger dogs. Anim. Genet. 2017, 48, 732–733, doi:10.1111/age.12612. 
Becker, D.; Minor, K.M.; Letko, A.; Ekenstedt, K.J.; Jagannathan, V.; Leeb, T.; Shelton, G.D.; 
Mickelson, J.R.; Drögemüller, C. A GJA9 frameshift variant is associated with polyneuropathy 
in Leonberger dogs. BMC Genomics 2017, 18, 662, doi:10.1186/s12864-017-4081-z. 
Unpublished articles 
Bannasch, D.L.; Kaelin, C.B.; Letko, A.; Loechel, R.; Hug, P.; Jagannathan, V.; Henkel, J.; 
Roosje, P.; Hytönen, M.K.; Lohi, H.; Arumilli, M.; DoGA consortium; Minor, K.M.; Mickelson, 
J.R.; Drögemüller, C.; Barsh, G.S.; Leeb, T. Dog color patterns explained by modular 
promoters of ancient canid origin. Nat. Ecol. Evol. 2021. In revision 
(https://www.biorxiv.org/content/10.1101/2020.12.21.423812v1). 
Conference abstracts 
Letko, A.; Grahofer, A.; Häfliger I.M.; Jagannathan, V.; Ducos, A.; Richard, O.; Peter, V.; 
Nathues, H.; Drögemüller, C. Array genotyping and/or whole genome sequencing facilitates 
detection of structural variants and chromosomal imbalance in pigs. Conference of the 
International Society for Animal Genetics, Lleida, Spain, Jul 7-12 2019. 
Letko, A.; Minor, K.M.; Jagannathan, V.; Seefried, F.R.; Oliehoek, P.; Mickelson, J.R.; 
Drögemüller, C. Leonberger dogs at risk: predisposition for diseases and inbreeding. 10th 
International Conference on Canine and Feline Genetics and Genomics, Bern, Switzerland, 
May 26-29 2019. 
Letko, A.; Grahofer, A.; Häfliger I.M.; Jagannathan, V.; Ducos, A.; Richard, O.; Peter, V.; 
Nathues, H.; Drögemüller, C. Array genotyping and/or whole genome sequencing facilitates 
detection of structural variants and chromosomal imbalance in pigs. Symposium of the Swiss 
Association of Animal Sciences, Lindau, Switzerland, Apr 16 2019. 
Letko, A.; Minor, K.M.; Mickelson, J.R.; Seefried, F.R.; Drögemüller, C. Population structure 
of Leonberger dogs. Companion Animal Genetic Health conference, Edinburgh, UK, May 14-
15 2018. Published in: Selected canine abstracts from the Companion Animal Genetic Health 
conference 2018 (CAGH 2018): Canine Genetics and Epidemiology. Canine Genet. Epidemiol. 
2018, 5, 7, doi:10.1186/s40575-018-0062-z. 
Letko, A.; Minor, K.M.; Mickelson, J.R.; Drögemüller, C. Rare forms of canine neurological 
disorders in Leonberger breed. The 4th International Workshop of Veterinary Neuroscience, 
Bern, Switzerland, Feb 16-17 2018. 
Letko, A.; Minor, K.M.; Becker, D.; Ekenstedt, K.J.; Mickelson, J.R.; Drögemüller, C. Update 
on polyneuropathy in Leonberger dogs. 9th International Conference on Canine and Feline 





1.  Ostrander, E.; Ruvinsky, A. The genetics of the dog; Ostrander, E.A., Ruvinsky, A., 
Eds.; 2nd ed.; CABI: Wallingford, 2012; ISBN 9781845939403. 
2.  Mellersh, C. Give a dog a genome. Vet. J. 2008, 178, 46–52, 
doi:10.1016/j.tvjl.2007.06.029. 
3.  Frantz, L.A.F.; Mullin, V.E.; Pionnier-Capitan, M.; Lebrasseur, O.; Ollivier, M.; Perri, A.; 
Linderholm, A.; Mattiangeli, V.; Teasdale, M.D.; Dimopoulos, E.A.; et al. Genomic and 
archaeological evidence suggest a dual origin of domestic dogs. Science 2016, 352, 
1228–1231, doi:10.1126/science.aaf3161. 
4.  Larson, G.; Karlsson, E.K.; Perri, A.; Webster, M.T.; Ho, S.Y.W.; Peters, J.; Stahl, 
P.W.; Piper, P.J.; Lingaas, F.; Fredholm, M.; et al. Rethinking dog domestication by 
integrating genetics, archeology, and biogeography. Proc. Natl. Acad. Sci. 2012, 109, 
8878–8883, doi:10.1073/pnas.1203005109. 
5.  Perri, A. A wolf in dog’s clothing: Initial dog domestication and Pleistocene wolf 
variation. J. Archaeol. Sci. 2016, 68, 1–4, doi:10.1016/j.jas.2016.02.003. 
6.  Nielsen, R. Molecular Signatures of Natural Selection. Annu. Rev. Genet. 2005, 39, 
197–218, doi:10.1146/annurev.genet.39.073003.112420. 
7.  Vonholdt, B.M.; Pollinger, J.P.; Lohmueller, K.E.; Han, E.; Parker, H.G.; Quignon, P.; 
Degenhardt, J.D.; Boyko, A.R.; Earl, D.A.; Auton, A.; et al. Genome-wide SNP and 
haplotype analyses reveal a rich history underlying dog domestication. Nature 2010, 
464, 898–902, doi:10.1038/nature08837. 
8.  Ostrander, E.A.; Wayne, R.K.; Freedman, A.H.; Davis, B.W. Demographic history, 
selection and functional diversity of the canine genome. Nat. Rev. Genet. 2017, 18, 
705–720, doi:10.1038/nrg.2017.67. 
9.  Ostrander, E.A.; Wayne, R.K. The canine genome. Genome Res. 2005, 15, 1706–
1716, doi:10.1101/gr.3736605. 
10.  Fédération Cynologique Internationale Available online: http://www.fci.be/en/ 
(accessed on Feb 23, 2021). 
11.  Andersson, L. Domestic animals as models for biomedical research. Ups. J. Med. Sci. 
2016, 121, 1–11, doi:10.3109/03009734.2015.1091522. 
12.  Hytönen, M.K.; Lohi, H. Canine models of human rare disorders. Rare Dis. 2016, 4, 1–
6, doi:10.1080/21675511.2016.1241362. 
13.  Online Mendelian Inheritance in Man, OMIM. McKusick-Nathans Institute of Genetic 
Medicine, Johns Hopkins University (Baltimore, MD) Available online: 
https://omim.org/ (accessed on Mar 18, 2020). 
14.  Online Mendelian Inheritance in Animals, OMIA. Sydney School of Veterinary Science 
Available online: https://omia.org/ (accessed on Mar 18, 2020). 
15.  Gough, A.; Thomas, A.; O’Neill, D. Breed predispositions to disease in dogs and cats: 
Third Edition; 2018; ISBN 9781119225584. 
16.  Clamp, M.; Fry, B.; Kamal, M.; Xie, X.; Cuff, J.; Lin, M.F.; Kellis, M.; Lindblad-Toh, K.; 
Lander, E.S. Distinguishing protein-coding and noncoding genes in the human 
genome. Proc. Natl. Acad. Sci. 2007, 104, 19428–19433, 
doi:10.1073/pnas.0709013104. 
17.  Lindblad-Toh, K.; Wade, C.M.; Mikkelsen, T.S.; Karlsson, E.K.; Jaffe, D.B.; Kamal, M.; 
Clamp, M.; Chang, J.L.; Kulbokas, E.J.; Zody, M.C.; et al. Genomic sequence, 




18.  Shaffer, L.G. Special issue on canine genetics: animal models for human disease and 
gene therapies, new discoveries for canine inherited diseases, and standards and 
guidelines for clinical genetic testing for domestic dogs. Hum. Genet. 2019, 138, 437–
440, doi:10.1007/s00439-019-02025-5. 
19.  Ashley, E.A. Towards precision medicine. Nat. Rev. Genet. 2016, 17, 507–522, 
doi:10.1038/nrg.2016.86. 
20.  Jagannathan, V.; Drögemüller, C.; Leeb, T.; Dog Biomedical Variant Database 
Consortium, (DBVDC). A comprehensive biomedical variant catalogue based on 
whole genome sequences of 582 dogs and eight wolves. Anim. Genet. 2019, 50, 695–
704, doi:10.1111/age.12834. 
21.  Vallat, J.-M.; Goizet, C.; Tazir, M.; Couratier, P.; Magy, L.; Mathis, S. Classifications of 
neurogenetic diseases: An increasingly complex problem. Rev. Neurol. (Paris). 2016, 
172, 339–349, doi:10.1016/j.neurol.2016.04.005. 
22.  Sisó, S.; Hanzlíček, D.; Fluehmann, G.; Kathmann, I.; Tomek, A.; Papa, V.; 
Vandevelde, M. Neurodegenerative diseases in domestic animals: A comparative 
review. Vet. J. 2006, 171, 20–38, doi:10.1016/j.tvjl.2004.08.015. 
23.  Katona, I.; Weis, J. Diseases of the peripheral nerves. In Handbook of Clinical 
Neurology; Elsevier B.V., 2018; Vol. 145, pp. 453–474; ISBN 9780128023952. 
24.  Willemsen, M.A.; Harting, I.; Wevers, R.A. Neurometabolic disorders. Neurol. Clin. 
Pract. 2016, 6, 348–357, doi:10.1212/CPJ.0000000000000266. 
25.  Braund, K.G.; Neuropathic Disorders. In Clinical Neurology in Small Animals - 
Localization, Diagnosis and Treatment; Vite, C.H., Ed.; International Veterinary 
Information Service: Ithaca, New York, USA, 2003. 
26.  Correard, S.; Plassais, J.; Lagoutte, L.; Botherel, N.; Thibaud, J.-L.; Hédan, B.; 
Richard, L.; Lia, A.-S.; Delague, V.; Mège, C.; et al. Canine neuropathies: powerful 
spontaneous models for human hereditary sensory neuropathies. Hum. Genet. 2019, 
138, 455–466, doi:10.1007/s00439-019-02003-x. 
27.  Fridman, V.; Reilly, M. Inherited Neuropathies. Semin. Neurol. 2015, 35, 407–423, 
doi:10.1055/s-0035-1558981. 
28.  Rudnik-Schöneborn, S.; Auer-Grumbach, M.; Senderek, J. Hereditary Neuropathies: 
Update 2017. Neuropediatrics 2017, 48, 282–293, doi:10.1055/s-0037-1603518. 
29.  Reilly, M.M.; Murphy, S.M.; Laurá, M. Charcot-Marie-Tooth disease. J. Peripher. Nerv. 
Syst. 2011, 16, 1–14, doi:10.1111/j.1529-8027.2011.00324.x. 
30.  Morena, J.; Gupta, A.; Hoyle, J.C. Charcot-Marie-Tooth: From Molecules to Therapy. 
Int. J. Mol. Sci. 2019, 20, 3419, doi:10.3390/ijms20143419. 
31.  Granger, N. Canine inherited motor and sensory neuropathies: An updated 
classification in 22 breeds and comparison to Charcot-Marie-Tooth disease. Vet. J. 
2011, 188, 274–285, doi:10.1016/j.tvjl.2010.06.003. 
32.  Kitshoff, A.M.; Van Goethem, B.; Stegen, L.; Vandekerckhov, P.; De Rooster, H. 
Laryngeal paralysis in dogs: An update on recent knowledge. J. S. Afr. Vet. Assoc. 
2013, 84, 1–9, doi:10.4102/jsava.v84i1.909. 
33.  Monnet, E. Surgical Treatment of Laryngeal Paralysis. Vet. Clin. North Am. - Small 
Anim. Pract. 2016, 46, 709–717, doi:10.1016/j.cvsm.2016.02.003. 
34.  Coates, J.R.; O’Brien, D.P. Inherited peripheral neuropathies in dogs and cats. Vet. 
Clin. North Am. Small Anim. Pract. 2004, 34, 1361–1401, 
doi:10.1016/j.cvsm.2004.05.011. 
35.  Waxman, S.G.; Ritchie, J.M. Molecular dissection of the myelinated axon. Ann. 
Neurol. 1993, 33, 121–136, doi:10.1002/ana.410330202. 
 
149 
36.  Duncan, I.D.; Radcliff, A.B. Inherited and acquired disorders of myelin: The underlying 
myelin pathology. Exp. Neurol. 2016, 283, 452–475, 
doi:10.1016/j.expneurol.2016.04.002. 
37.  Kaye, E.M. Update on genetic disorders affecting white matter. Pediatr. Neurol. 2001, 
24, 11–24, doi:10.1016/S0887-8994(00)00232-0. 
38.  Vanderver, A.; Prust, M.; Tonduti, D.; Mochel, F.; Hussey, H.M.; Helman, G.; Garbern, 
J.; Eichler, F.; Labauge, P.; Aubourg, P.; et al. Case definition and classification of 
leukodystrophies and leukoencephalopathies. Mol. Genet. Metab. 2015, 114, 494–
500, doi:10.1016/j.ymgme.2015.01.006. 
39.  Salsano, E. Leukodystrophy or genetic leukoencephalopathy? Nature does not make 
leaps. Mol. Genet. Metab. 2015, 114, 491–493, doi:10.1016/j.ymgme.2015.02.005. 
40.  Schiffmann, R.; Van Der Knaap, M.S. Invited Article: An MRI-based approach to the 
diagnosis of white matter disorders. Neurology 2009, 72, 750–759, 
doi:10.1212/01.wnl.0000343049.00540.c8. 
41.  Wang, X.; He, F.; Yin, F.; Chen, C.; Wu, L.; Yang, L.; Peng, J. The use of targeted 
genomic capture and massively parallel sequencing in diagnosis of Chinese 
Leukoencephalopathies. Sci. Rep. 2016, 6, 35936, doi:10.1038/srep35936. 
42.  Robert, N. Neurologic Disorders in Cheetahs and Snow Leopards. In Zoo and Wild 
Animal Medicine; Fowler, M.E., Miller, R.E., Eds.; Elsevier, 2008; ISBN 
9781416040477. 
43.  Andersen, H.A.; Palludan, B. Leucodystrophy in mink. Acta Neuropathol. 1968, 11, 
347–360, doi:10.1007/BF00686731. 
44.  Story, B.D.; Miller, M.E.; Bradbury, A.M.; Million, E.D.; Duan, D.; Taghian, T.; Faissler, 
D.; Fernau, D.; Beecy, S.J.; Gray-Edwards, H.L. Canine Models of Inherited 
Musculoskeletal and Neurodegenerative Diseases. Front. Vet. Sci. 2020, 7, 80, 
doi:10.3389/fvets.2020.00080. 
45.  Coates, J.R.; Wininger, F.A. Canine degenerative myelopathy. Vet. Clin. North Am. - 
Small Anim. Pract. 2010, 40, 929–950. 
46.  Davies, D.R.; Irwin, P.J. Degenerative neurological and neuromuscular disease in 
young rottweilers. J. Small Anim. Pract. 2003, 44, 388–394, doi:10.1111/j.1748-
5827.2003.tb00173.x. 
47.  Oevermann, A.; Bley, T.; Konar, M.; Lang, J.; Vandevelde, M. A Novel 
Leukoencephalomyelopathy of Leonberger Dogs. J. Vet. Intern. Med. 2008, 22, 467–
471, doi:10.1111/j.1939-1676.2008.0068.x. 
48.  Hayflick, S.J.; Kurian, M.A.; Hogarth, P. Neurodegeneration with brain iron 
accumulation. Handb. Clin. Neurol. 2018, 147, 293–305, doi:10.1016/B978-0-444-
63233-3.00019-1. 
49.  Gregory, A.; Polster, B.J.; Hayflick, S.J. Clinical and genetic delineation of 
neurodegeneration with brain iron accumulation. J. Med. Genet. 2008, 46, 73–80, 
doi:10.1136/jmg.2008.061929. 
50.  Carrilho, I.; Santos, M.; Guimarães, A.; Teixeira, J.; Chorão, R.; Martins, M.; Dias, C.; 
Gregory, A.; Westaway, S.; Nguyen, T.; et al. Infantile neuroaxonal dystrophy: What’s 
most important for the diagnosis? Eur. J. Paediatr. Neurol. 2008, 12, 491–500, 
doi:10.1016/j.ejpn.2008.01.005. 
51.  Letko, A.; Strugnell, B.; Häfliger, I.M.; Paris, J.M.; Waine, K.; Drögemüller, C.; Scholes, 
S. Compound heterozygous PLA2G6 loss-of-function variants in Swaledale sheep with 




52.  Fyfe, J.C.; Al-Tamimi, R.A.; Liu, J.; Schäffer, A.A.; Agarwala, R.; Henthorn, P.S. A 
novel mitofusin 2 mutation causes canine fetal-onset neuroaxonal dystrophy. 
Neurogenetics 2011, 12, 223–232, doi:10.1007/s10048-011-0285-6. 
53.  Hahn, K.; Rohdin, C.; Jagannathan, V.; Wohlsein, P.; Baumgärtner, W.; Seehusen, F.; 
Spitzbarth, I.; Grandon, R.; Drögemüller, C.; Jäderlund, K.H. TECPR2 associated 
neuroaxonal dystrophy in Spanish water dogs. PLoS One 2015, 10, 1–18, 
doi:10.1371/journal.pone.0141824. 
54.  Lucot, K.L.; Dickinson, P.J.; Finno, C.J.; Mansour, T.A.; Letko, A.; Minor, K.M.; 
Mickelson, J.R.; Drögemüller, C.; Brown, C.T.; Bannasch, D.L. A Missense Mutation in 
the Vacuolar Protein Sorting 11 (VPS11) Gene Is Associated with Neuroaxonal 
Dystrophy in Rottweiler Dogs. G3 (Bethesda) 2018, 8, 2773–2780, 
doi:10.1534/g3.118.200376. 
55.  Synofzik, M.; Schüle, R. Overcoming the divide between ataxias and spastic 
paraplegias: Shared phenotypes, genes, and pathways. Mov. Disord. 2017, 32, 332–
345, doi:10.1002/mds.26944. 
56.  Manto, M.; Marmolino, D. Cerebellar ataxias. Curr. Opin. Neurol. 2009, 22, 419–429, 
doi:10.1097/WCO.0b013e32832b9897. 
57.  Urkasemsin, G.; Olby, N.J. Canine Hereditary Ataxia. Vet. Clin. North Am. Small Anim. 
Pract. 2014, 44, 1075–1089, doi:10.1016/j.cvsm.2014.07.005. 
58.  El-Hattab, A.W. Inborn Errors of Metabolism. Clin. Perinatol. 2015, 42, 413–439, 
doi:10.1016/j.clp.2015.02.010. 
59.  Kamboj, M. Clinical Approach to the Diagnoses of Inborn Errors of Metabolism. 
Pediatr. Clin. North Am. 2008, 55, 1113–1127, doi:10.1016/j.pcl.2008.07.004. 
60.  Saudubray, J.-M.; Garcia-Cazorla, A. An overview of inborn errors of metabolism 
affecting the brain: from neurodevelopment to neurodegenerative disorders. Dialogues 
Clin. Neurosci. 2018, 20, 301–326, doi:10.31887/DCNS.2018.20.4/jmsaudubray. 
61.  Sewell, A.C.; Haskins, M.E.; Giger, U. Inherited metabolic disease in companion 
animals: Searching for nature’s mistakes. Vet. J. 2007, 174, 252–259, 
doi:10.1016/j.tvjl.2006.08.017. 
62.  Leeb, T. Animal DNA diagnostics – Personal genomics for our pets and livestock is at 
the Horizon. Mol. Cell. Probes 2012, 26, 223, doi:10.1016/j.mcp.2012.09.001. 
63.  Mellersh, C.S.; Langston, A.A.; Acland, G.M.; Fleming, M.A.; Ray, K.; Wiegand, N.A.; 
Francisco, L. V.; Gibbs, M.; Aguirre, G.D.; Ostrander, E.A. A Linkage Map of the 
Canine Genome. Genomics 1997, 46, 326–336, doi:10.1006/geno.1997.5098. 
64.  Karlsson, E.K.; Lindblad-Toh, K. Leader of the pack: gene mapping in dogs and other 
model organisms. Nat. Rev. Genet. 2008, 9, 713–725, doi:10.1038/nrg2382. 
65.  Leegwater, P.A.; van Hagen, M.A.; van Oost, B.A. Localization of White Spotting 
Locus in Boxer Dogs on CFA20 by Genome-Wide Linkage Analysis with 1500 SNPs. 
J. Hered. 2007, 98, 549–552, doi:10.1093/jhered/esm022. 
66.  Drögemüller, C.; Becker, D.; Brunner, A.; Haase, B.; Kircher, P.; Seeliger, F.; Fehr, M.; 
Baumann, U.; Lindblad-Toh, K.; Leeb, T. A Missense Mutation in the SERPINH1 Gene 
in Dachshunds with Osteogenesis Imperfecta. PLoS Genet. 2009, 5, e1000579, 
doi:10.1371/journal.pgen.1000579. 
67.  Karlsson, E.K.; Baranowska, I.; Wade, C.M.; Salmon Hillbertz, N.H.C.; Zody, M.C.; 
Anderson, N.; Biagi, T.M.; Patterson, N.; Pielberg, G.R.; Kulbokas, E.J.; et al. Efficient 
mapping of mendelian traits in dogs through genome-wide association. Nat. Genet. 
2007, 39, 1321–1328, doi:10.1038/ng.2007.10. 
68.  Drögemüller, C.; Karlsson, E.K.; Hytönen, M.K.; Perloski, M.; Dolf, G.; Sainio, K.; Lohi, 
 
151 
H.; Lindblad-Toh, K.; Leeb, T. A Mutation in Hairless Dogs Implicates FOXI3 in 
Ectodermal Development. Science 2008, 321, 1462–1462, 
doi:10.1126/science.1162525. 
69.  McGinn, S.; Gut, I.G. DNA sequencing – spanning the generations. N. Biotechnol. 
2013, 30, 366–372, doi:10.1016/j.nbt.2012.11.012. 
70.  Drögemüller, M.; Jagannathan, V.; Howard, J.; Bruggmann, R.; Drögemüller, C.; 
Ruetten, M.; Leeb, T.; Kook, P.H. A frameshift mutation in the cubilin gene (CUBN) in 
Beagles with Imerslund-Gräsbeck syndrome (selective cobalamin malabsorption). 
Anim. Genet. 2014, 45, 148–150, doi:10.1111/age.12094. 
71.  Guevar, J.; Olby, N.J.; Meurs, K.M.; Yost, O.; Friedenberg, S.G. Deafness and 
vestibular dysfunction in a Doberman Pinscher puppy associated with a mutation in 
the PTPRQ gene. J. Vet. Intern. Med. 2018, 32, 665–669, doi:10.1111/jvim.15060. 
72.  Lepori, V.; Mühlhause, F.; Sewell, A.C.; Jagannathan, V.; Janzen, N.; Rosati, M.; 
Alves de Sousa, F.M.M.; Tschopp, A.; Schüpbach, G.; Matiasek, K.; et al. A Nonsense 
Variant in the ACADVL Gene in German Hunting Terriers with Exercise Induced 
Metabolic Myopathy. G3 (Bethesda) 2018, 8, 1545–1554, doi:10.1534/g3.118.200084. 
73.  Drögemüller, M.; Jagannathan, V.; Becker, D.; Drögemüller, C.; Schelling, C.; 
Plassais, J.; Kaerle, C.; Dufaure de Citres, C.; Thomas, A.; Müller, E.J.; et al. A 
Mutation in the FAM83G Gene in Dogs with Hereditary Footpad Hyperkeratosis 
(HFH). PLoS Genet. 2014, 10, e1004370, doi:10.1371/journal.pgen.1004370. 
74.  Gerber, M.; Fischer, A.; Jagannathan, V.; Drögemüller, M.; Drögemüller, C.; Schmidt, 
M.J.; Bernardino, F.; Manz, E.; Matiasek, K.; Rentmeister, K.; et al. A Deletion in the 
VLDLR Gene in Eurasier Dogs with Cerebellar Hypoplasia Resembling a Dandy-
Walker-Like Malformation (DWLM). PLoS One 2015, 10, e0108917, 
doi:10.1371/journal.pone.0108917. 
75.  Wielaender, F.; Sarviaho, R.; James, F.; Hytönen, M.K.; Cortez, M.A.; Kluger, G.; 
Koskinen, L.L.E.; Arumilli, M.; Kornberg, M.; Bathen-Noethen, A.; et al. Generalized 
myoclonic epilepsy with photosensitivity in juvenile dogs caused by a defective DIRAS 
family GTPase 1. Proc. Natl. Acad. Sci. 2017, 114, 2669–2674, 
doi:10.1073/pnas.1614478114. 
76.  Letko, A.; Zdora, I.; Hitzler, V.; Jagannathan, V.; Beineke, A.; Möhrke, C.; 
Drögemüller, C. A de novo in‐frame duplication in the COL1A2 gene in a Lagotto 
Romagnolo dog with osteogenesis imperfecta. Anim. Genet. 2019, 50, 786–787, 
doi:10.1111/age.12843. 
77.  Murgiano, L.; Becker, D.; Torjman, D.; Niggel, J.K.; Milano, A.; Cullen, C.; Feng, R.; 
Wang, F.; Jagannathan, V.; Pearce-Kelling, S.; et al. Complex Structural PPT1 Variant 
Associated with Non-syndromic Canine Retinal Degeneration. G3 (Bethesda) 2018, 9, 
g3.200859.2018, doi:10.1534/g3.118.200859. 
78.  Mauri, N.; Kleiter, M.; Dietschi, E.; Leschnik, M.; Högler, S.; Wiedmer, M.; Dietrich, J.; 
Henke, D.; Steffen, F.; Schuller, S.; et al. A SINE Insertion in ATP1B2 in Belgian 
Shepherd Dogs Affected by Spongy Degeneration with Cerebellar Ataxia (SDCA2). 
G3 (Bethesda) 2017, 7, 2729–2737, doi:10.1534/g3.117.043018. 
79.  Hirz, M.; Drögemüller, M.; Schänzer, A.; Jagannathan, V.; Dietschi, E.; Goebel, H.H.; 
Hecht, W.; Laubner, S.; Schmidt, M.J.; Steffen, F.; et al. Neuronal ceroid lipofuscinosis 
(NCL) is caused by the entire deletion of CLN8 in the Alpenländische Dachsbracke 
dog. Mol. Genet. Metab. 2017, 120, 269–277, doi:10.1016/j.ymgme.2016.12.007. 
80.  Lequarré, A.S.; Andersson, L.; André, C.; Fredholm, M.; Hitte, C.; Leeb, T.; Lohi, H.; 
Lindblad-Toh, K.; Georges, M. LUPA: A European initiative taking advantage of the 
canine genome architecture for unravelling complex disorders in both human and 
dogs. Vet. J. 2011, 189, 155–159. 
 
152 
81.  Friedenberg, S.G.; Meurs, K.M. Genotype imputation in the domestic dog. Mamm. 
Genome 2016, 27, 485–494, doi:10.1007/s00335-016-9636-9. 
82.  Hayward, J.J.; White, M.E.; Boyle, M.; Shannon, L.M.; Casal, M.L.; Castelhano, M.G.; 
Center, S.A.; Meyers-Wallen, V.N.; Simpson, K.W.; Sutter, N.B.; et al. Imputation of 
canine genotype array data using 365 whole-genome sequences improves power of 
genome-wide association studies. PLOS Genet. 2019, 15, e1008003, 
doi:10.1371/journal.pgen.1008003. 
83.  Teare, M.D.; Santibanez Koref, M.F. Linkage analysis and the study of Mendelian 
disease in the era of whole exome and genome sequencing. Brief. Funct. Genomics 
2014, 13, 378–383, doi:10.1093/bfgp/elu024. 
84.  Ott, J.; Wang, J.; Leal, S.M. Genetic linkage analysis in the age of whole-genome 
sequencing. Nat. Rev. Genet. 2015, 16, 275–284. 
85.  Sams, A.J.; Boyko, A.R. Fine-Scale Resolution of Runs of Homozygosity Reveal 
Patterns of Inbreeding and Substantial Overlap with Recessive Disease Genotypes in 
Domestic Dogs. G3 (Bethesda) 2019, 9, 117–123, doi:10.1534/g3.118.200836. 
86.  Vahidnezhad, H.; Youssefian, L.; Jazayeri, A.; Uitto, J. Research Techniques Made 
Simple: Genome-Wide Homozygosity/Autozygosity Mapping Is a Powerful Tool for 
Identifying Candidate Genes in Autosomal Recessive Genetic Diseases. J. Invest. 
Dermatol. 2018, 138, 1893–1900, doi:10.1016/j.jid.2018.06.170. 
87.  Curik, I.; Ferenčaković, M.; Sölkner, J. Inbreeding and runs of homozygosity: A 
possible solution to an old problem. Livest. Sci. 2014, 166, 26–34, 
doi:10.1016/j.livsci.2014.05.034. 
88.  Gondro, C.; Porto-Neto, L.R.; Lee, S.H. Genome-Wide Association Studies and 
Genomic Prediction. In Methods in Molecular Biology; Gondro, C., van der Werf, J., 
Hayes, B., Eds.; Humana Press: Totowa, NJ, 2013; Vol. 1019; ISBN 978-1-62703-
446-3. 
89.  Ekenstedt, K.J.; Becker, D.; Minor, K.M.; Shelton, G.D.; Patterson, E.E.; Bley, T.; 
Oevermann, A.; Bilzer, T.; Leeb, T.; Drögemüller, C.; et al. An ARHGEF10 Deletion Is 
Highly Associated with a Juvenile-Onset Inherited Polyneuropathy in Leonberger and 
Saint Bernard Dogs. PLoS Genet. 2014, 10, e1004635, 
doi:10.1371/journal.pgen.1004635. 
90.  Price, A.L.; Zaitlen, N.A.; Reich, D.; Patterson, N. New approaches to population 
stratification in genome-wide association studies. Nat. Rev. Genet. 2010, 11, 459–463, 
doi:10.1038/nrg2813. 
91.  Mealey, K.L.; Martinez, S.E.; Villarino, N.F.; Court, M.H. Personalized medicine: going 
to the dogs? Hum. Genet. 2019, 138, 467–481, doi:10.1007/s00439-019-02020-w. 
92.  Gauthier, J.; Vincent, A.T.; Charette, S.J.; Derome, N. A brief history of bioinformatics. 
Brief. Bioinform. 2019, 20, 1981–1996, doi:10.1093/bib/bby063. 
93.  Kumar, K.R.; Cowley, M.J.; Davis, R.L. Next-Generation Sequencing and Emerging 
Technologies. Semin. Thromb. Hemost. 2019, 45, 661–673, doi:10.1055/s-0039-
1688446. 
94.  Koboldt, D.C.; Steinberg, K.M.; Larson, D.E.; Wilson, R.K.; Mardis, E.R. The Next-
Generation Sequencing Revolution and Its Impact on Genomics. Cell 2013, 155, 27–
38, doi:10.1016/j.cell.2013.09.006. 
95.  Depristo, M.A.; Banks, E.; Poplin, R.; Garimella, K. V.; Maguire, J.R.; Hartl, C.; 
Philippakis, A.A.; Del Angel, G.; Rivas, M.A.; Hanna, M.; et al. A framework for 
variation discovery and genotyping using next-generation DNA sequencing data. Nat. 
Genet. 2011, 43, 491–501, doi:10.1038/ng.806. 
96.  McKenna, A.; Hanna, M.; Banks, E.; Sivachenko, A.; Cibulskis, K.; Kernytsky, A.; 
 
153 
Garimella, K.; Altshuler, D.; Gabriel, S.; Daly, M.; et al. The Genome Analysis Toolkit: 
A MapReduce framework for analyzing next-generation DNA sequencing data. 
Genome Res. 2010, 20, 1297–1303, doi:10.1101/gr.107524.110. 
97.  Dunham, I.; Kundaje, A.; Aldred, S.F.; Collins, P.J.; Davis, C.A.; Doyle, F.; Epstein, 
C.B.; Frietze, S.; Harrow, J.; Kaul, R.; et al. An integrated encyclopedia of DNA 
elements in the human genome. Nature 2012, 489, 57–74, doi:10.1038/nature11247. 
98.  Plassais, J.; Kim, J.; Davis, B.W.; Karyadi, D.M.; Hogan, A.N.; Harris, A.C.; Decker, B.; 
Parker, H.G.; Ostrander, E.A. Whole genome sequencing of canids reveals genomic 
regions under selection and variants influencing morphology. Nat. Commun. 2019, 10, 
1–14, doi:10.1038/s41467-019-09373-w. 
99.  Ostrander, E.A.; Wang, G.D.; Larson, G.; Vonholdt, B.M.; Davis, B.W.; Jagannathan, 
V.; Hitte, C.; Wayne, R.K.; Zhang, Y.P.; André, C.; et al. Dog10K: An international 
sequencing effort to advance studies of canine domestication, phenotypes and health. 
Natl. Sci. Rev. 2019, 6, 810–824. 
100.  Dog Genome Assembled. National Human Genome Research Institute. Available 
online: https://www.genome.gov/12511476/2004-advisory-dog-genome-assembled 
(accessed on Mar 11, 2021). 
101.  Hoeppner, M.P.; Lundquist, A.; Pirun, M.; Meadows, J.R.S.; Zamani, N.; Johnson, J.; 
Sundström, G.; Cook, A.; FitzGerald, M.G.; Swofford, R.; et al. An improved canine 
genome and a comprehensive catalogue of coding genes and non-coding transcripts. 
PLoS One 2014, 9, 91172, doi:10.1371/journal.pone.0091172. 
102.  Canis lupus familiaris Annotation Release 106. National Center for Biotechnology 
Information. Available online: 
https://www.ncbi.nlm.nih.gov/genome/annotation_euk/Canis_lupus_familiaris/106/ 
(accessed on Mar 4, 2021). 
103.  Dog10K_Boxer_Tasha - Genome - Assembly - NCBI. Dog Genome Sequencing 
Consortium. Available online: 
https://www.ncbi.nlm.nih.gov/assembly/GCF_000002285.5/ (accessed on Mar 4, 
2021). 
104.  Halo, J. V.; Pendleton, A.L.; Shen, F.; Doucet, A.J.; Derrien, T.; Hitte, C.; Kirby, L.E.; 
Myers, B.; Sliwerska, E.; Emery, S.; et al. Long-read assembly of a Great Dane 
genome highlights the contribution of GC-rich sequence and mobile elements to 
canine genomes. Proc. Natl. Acad. Sci. 2021, 118, e2016274118, 
doi:10.1073/pnas.2016274118. 
105.  Wang, C.; Wallerman, O.; Arendt, M.-L.; Sundström, E.; Karlsson, Å.; Nordin, J.; 
Mäkeläinen, S.; Pielberg, G.R.; Hanson, J.; Ohlsson, Å.; et al. A novel canine 
reference genome resolves genomic architecture and uncovers transcript complexity. 
Commun. Biol. 2021, 4, 185, doi:10.1038/s42003-021-01698-x. 
106.  Edwards, R.J.; Field, M.A.; Ferguson, J.M.; Dudchenko, O.; Keilwagen, J.; Rosen, 
B.D.; Johnson, G.S.; Rice, E.; Hillier, L.D.; Hammond, J.M.; et al. Chromosome-length 
genome assembly and structural variations of the primal Basenji dog (Canis lupus 
familiaris) genome. bioRxiv 2020, 2020.11.11.379073, 
doi:10.1101/2020.11.11.379073. 
107.  ROS_Cfam_1.0 - Genome - Assembly - NCBI. The Roslin Institute. Available online: 
https://www.ncbi.nlm.nih.gov/assembly/GCF_014441545.1/ (accessed on Mar 4, 
2021). 
108.  Boccardo, A.; Marelli, S.P.; Pravettoni, D.; Bagnato, A.; Busca, G.A.; Strillacci, M.G. 
The German Shorthair Pointer Dog Breed (Canis lupus familiaris): Genomic 
Inbreeding and Variability. Animals (Basel). 2020, 10, 498, doi:10.3390/ani10030498. 
109.  Mastrangelo, S.; Filippo, B.; Auzino, B.; Marco, R.; Spaterna, A.; Ciampolini, R. 
 
154 
Genome-wide diversity and runs of homozygosity in the “Braque Français, type 
Pyrénées” dog breed. BMC Res. Notes 2018, 11, 11–16, doi:10.1186/s13104-017-
3112-9. 
110.  Mortlock, S.A.; Khatkar, M.S.; Williamson, P. Comparative analysis of genome 
diversity in bullmastiff dogs. PLoS One 2016, 11, 1–17, 
doi:10.1371/journal.pone.0147941. 
111.  Soh, P.X.Y.; Hsu, W.T.; Khatkar, M.S.; Williamson, P. Evaluation of genetic diversity 
and management of disease in Border Collie dogs. Sci. Rep. 2021, 11, 6243, 
doi:10.1038/s41598-021-85262-x. 
112.  Friedenberg, S.G.; Meurs, K.M.; Mackay, T.F.C. Evaluation of artificial selection in 
Standard Poodles using whole-genome sequencing. Mamm. Genome 2016, 27, 599–
609, doi:10.1007/s00335-016-9660-9. 
113.  Metzger, J.; Pfahler, S.; Distl, O. Variant detection and runs of homozygosity in next 
generation sequencing data elucidate the genetic background of Lundehund 
syndrome. BMC Genomics 2016, 17, doi:10.1186/s12864-016-2844-6. 
114.  Mastrangelo, S.; Biscarini, F.; Tolone, M.; Auzino, B.; Ragatzu, M.; Spaterna, A.; 
Ciampolini, R. Genomic characterization of the Braque Français type Pyrénées dog 
and relationship with other breeds. PLoS One 2018, 13, e0208548, 
doi:10.1371/journal.pone.0208548. 
115.  Caniglia, R.; Fabbri, E.; Hulva, P.; Bolfíková, B.Č.; Jindřichová, M.; Stronen, A.V.; 
Dykyy, I.; Camatta, A.; Carnier, P.; Randi, E.; et al. Wolf outside, dog inside? The 
genomic make-up of the Czechoslovakian Wolfdog. BMC Genomics 2018, 19, 533, 
doi:10.1186/s12864-018-4916-2. 
116.  Pfahler, S.; Distl, O. Effective Population Size, Extended Linkage Disequilibrium and 
Signatures of Selection in the Rare Dog Breed Lundehund. PLoS One 2015, 10, 
e0122680, doi:10.1371/journal.pone.0122680. 
117.  O’Brien, D.P.; Leeb, T. DNA Testing in Neurologic Diseases. J. Vet. Intern. Med. 2014, 
28, 1186–1198, doi:10.1111/jvim.12383. 
118.  Windig, J.J.; Doekes, H.P. Limits to genetic rescue by outcross in pedigree dogs. J. 
Anim. Breed. Genet. 2018, 135, 238–248, doi:10.1111/jbg.12330. 
119.  Kleopa, K.A.; Sargiannidou, I. Connexins, gap junctions and peripheral neuropathy. 
Neurosci. Lett. 2015, 596, 27–32. 
120.  Abrams, C.K.; Scherer, S.S. Gap junctions in inherited human disorders of the central 
nervous system. Biochim. Biophys. Acta - Biomembr. 2012, 1818, 2030–2047. 
121.  Freed, A.S.; Weiss, M.D.; Malouf, E.A.; Hisama, F.M. CNTNAP1 mutations in an adult 
with Charcot Marie Tooth disease. Muscle and Nerve 2019, 60, E28–E30, 
doi:10.1002/mus.26658. 
122.  Low, K.; Stals, K.; Caswell, R.; Clayton-Smith, J.; Donaldson, A.; Foulds, N.; Splitt, M.; 
Norman, A.; Urankar, K.; Vijayakumar, K.; et al. CNTNAP1: Extending the phenotype 
of congenital hypomyelinating neuropathy in 6 further patients. Neuromuscul. Disord. 
2017, 27, S148, doi:10.1016/j.nmd.2017.06.201. 
123.  Boyko, A.R.; Brooks, S.A.; Behan-Braman, A.; Castelhano, M.; Corey, E.; Oliveira, 
K.C.; Swinburne, J.E.; Todhunter, R.J.; Zhang, Z.; Ainsworth, D.M.; et al. Genomic 
analysis establishes correlation between growth and laryngeal neuropathy in 
Thoroughbreds. BMC Genomics 2014, 15, 1–9, doi:10.1186/1471-2164-15-259. 
124.  Wiedmer, M.; Oevermann, A.; Borer-Germann, S.E.; Gorgas, D.; Shelton, G.D.; 
Drögemüller, M.; Jagannathan, V.; Henke, D.; Leeb, T. A RAB3GAP1 SINE Insertion 
in Alaskan Huskies with Polyneuropathy, Ocular Abnormalities, and Neuronal 
Vacuolation (POANV) Resembling Human Warburg Micro Syndrome 1 (WARBM1). 
 
155 
G3 (Bethesda) 2016, 6, 255–262, doi:10.1534/g3.115.022707. 
125.  Mhlanga-Mutangadura, T.; Johnson, G.S.; Ashwini, A.; Shelton, G.D.; Wennogle, S.A.; 
Johnson, G.C.; Kuroki, K.; O’Brien, D.P. A Homozygous RAB3GAP1:c.743delC 
Mutation in Rottweilers with Neuronal Vacuolation and Spinocerebellar Degeneration. 
J. Vet. Intern. Med. 2016, 30, 813–818, doi:10.1111/jvim.13921. 
126.  Lu, H.C.; MacKie, K. An introduction to the endogenous cannabinoid system. Biol. 
Psychiatry 2016, 79, 516–525. 
127.  Cork, L.C.; Troncoso, J.C.; Price, D.L.; Stanley, E.F.; Griffin, J.W. Canine Neuroaxonal 
Dystrophy. J. Neuropathol. Exp. Neurol. 1983, 42, 286–296, doi:10.1097/00005072-
198305000-00006. 
128.  Plemel, R.L.; Lobingier, B.T.; Brett, C.L.; Angers, C.G.; Nickerson, D.P.; Paulsel, A.; 
Sprague, D.; Merz, A.J. Subunit organization and Rab interactions of Vps-C protein 
complexes that control endolysosomal membrane traffic. Mol. Biol. Cell 2011, 22, 
1353–1363, doi:10.1091/mbc.E10-03-0260. 
129.  Hörtnagel, K.; Krägeloh-Mann, I.; Bornemann, A.; Döcker, M.; Biskup, S.; Mayrhofer, 
H.; Battke, F.; du Bois, G.; Harzer, K. The second report of a new hypomyelinating 
disease due to a defect in the VPS11 gene discloses a massive lysosomal 
involvement. J. Inherit. Metab. Dis. 2016, 39, 849–857, doi:10.1007/s10545-016-9961-
x. 
130.  Catterall, W.A. Sodium Channels. Encycl. Life Sci. 2006, 65–71, 
doi:10.1038/npg.els.0000127. 
131.  Kearney, J.A.; Buchner, D.A.; De Haan, G.; Adamska, M.; Levin, S.I.; Furay, A.R.; 
Albin, R.L.; Jones, J.M.; Montal, M.; Stevens, M.J.; et al. Molecular and pathological 
effects of a modifier gene on deficiency of the sodium channel Scn8a (Na(v)1.6). Hum. 
Mol. Genet. 2002, 11, 2765–2775, doi:10.1093/hmg/11.22.2765. 
132.  Wagnon, J.L.; Mencacci, N.E.; Barker, B.S.; Wengert, E.R.; Bhatia, K.P.; Balint, B.; 
Carecchio, M.; Wood, N.W.; Patel, M.K.; Meisler, M.H. Partial loss-of-function of 
sodium channel SCN8A in familial isolated myoclonus. Hum. Mutat. 2018, 39, 965–
969, doi:10.1002/humu.23547. 
133.  Pearl, P.L.; Parviz, M.; Vogel, K.; Schreiber, J.; Theodore, W.H.; Gibson, K.M. 
Inherited disorders of gamma-aminobutyric acid metabolism and advances in 
ALDH5A1 mutation identification. Dev. Med. Child Neurol. 2015, 57, 611–617, 
doi:10.1111/dmcn.12668. 
134.  DiBacco, M.L.; Pop, A.; Salomons, G.S.; Hanson, E.; Roullet, J.-B.; Gibson, K.M.; 
Pearl, P.L. Novel ALDH5A1 variants and genotype. Neurology 2020, 95, e2675–
e2682, doi:10.1212/WNL.0000000000010730. 
135.  Didiasova, M.; Banning, A.; Brennenstuhl, H.; Jung-Klawitter, S.; Cinquemani, C.; 
Opladen, T.; Tikkanen, R. Succinic Semialdehyde Dehydrogenase Deficiency: An 
Update. Cells 2020, 9, 477, doi:10.3390/cells9020477. 
136.  Wakshlag, J.J.; Lahunta, A. de; Robinson, T.; Cooper, B.J.; Brenner, O.; O’Toole, 
T.D.; Olson, J.; Beckman, K.B.; Glass, E.; Reynolds, A.J. Subacute necrotising 
encephalopathy in an Alaskan husky. J. Small Anim. Pract. 1999, 40, 585–589, 
doi:10.1111/j.1748-5827.1999.tb03028.x. 
137.  Baiker, K.; Hofmann, S.; Fischer, A.; Gödde, T.; Medl, S.; Schmahl, W.; Bauer, M.F.; 
Matiasek, K. Leigh-like subacute necrotising encephalopathy in Yorkshire Terriers: 
neuropathological characterisation, respiratory chain activities and mitochondrial DNA. 
Acta Neuropathol. 2009, 118, 697–709, doi:10.1007/s00401-009-0548-6. 
138.  Gerards, M.; Sallevelt, S.C.E.H.; Smeets, H.J.M. Leigh syndrome: Resolving the 
clinical and genetic heterogeneity paves the way for treatment options. Mol. Genet. 
 
156 
Metab. 2016, 117, 300–312, doi:10.1016/j.ymgme.2015.12.004. 
139.  Gerards, M.; Kamps, R.; van Oevelen, J.; Boesten, I.; Jongen, E.; de Koning, B.; 
Scholte, H.R.; de Angst, I.; Schoonderwoerd, K.; Sefiani, A.; et al. Exome sequencing 
reveals a novel Moroccan founder mutation in SLC19A3 as a new cause of early-
childhood fatal Leigh syndrome. Brain 2013, 136, 882–890, doi:10.1093/brain/awt013. 
140.  Whitford, W.; Hawkins, I.; Glamuzina, E.; Wilson, F.; Marshall, A.; Ashton, F.; Love, 
D.R.; Taylor, J.; Hill, R.; Lehnert, K.; et al. Compound heterozygous SLC19A3 
mutations further refine the critical promoter region for biotin-thiamine-responsive 
basal ganglia disease. Mol. Case Stud. 2017, 3, a001909, doi:10.1101/mcs.a001909. 
141.  Vernau, K.M.; Runstadler, J.A.; Brown, E.A.; Cameron, J.M.; Huson, H.J.; Higgins, 
R.J.; Ackerley, C.; Sturges, B.K.; Dickinson, P.J.; Puschner, B.; et al. Genome-Wide 
Association Analysis Identifies a Mutation in the Thiamine Transporter 2 (SLC19A3) 
Gene Associated with Alaskan Husky Encephalopathy. PLoS One 2013, 8, e57195, 
doi:10.1371/journal.pone.0057195. 
142.  Lewis, T.W.; Mellersh, C.S. Changes in mutation frequency of eight Mendelian 
inherited disorders in eight pedigree dog populations following introduction of a 
commercial DNA test. PLoS One 2019, 14, 1–21, doi:10.1371/journal.pone.0209864. 
143.  Drögemüller, C.; Reichart, U.; Seuberlich, T.; Oevermann, A.; Baumgartner, M.; Kühni 
Boghenbor, K.; Stoffel, M.H.; Syring, C.; Meylan, M.; Müller, S.; et al. An Unusual 
Splice Defect in the Mitofusin 2 Gene (MFN2) Is Associated with Degenerative 
Axonopathy in Tyrolean Grey Cattle. PLoS One 2011, 6, e18931, 
doi:10.1371/journal.pone.0018931. 
144.  Marian, A.J. Causality in Genetics. Circ. Res. 2014, 114, e18–e21, 
doi:10.1161/CIRCRESAHA.114.302904. 
145.  Richards, S.; Aziz, N.; Bale, S.; Bick, D.; Das, S.; Gastier-Foster, J.; Grody, W.W.; 
Hegde, M.; Lyon, E.; Spector, E.; et al. Standards and guidelines for the interpretation 
of sequence variants: a joint consensus recommendation of the American College of 
Medical Genetics and Genomics and the Association for Molecular Pathology. Genet. 
Med. 2015, 17, 405–423, doi:10.1038/gim.2015.30. 
146.  Rodenburg, R.J. The functional genomics laboratory: functional validation of genetic 
variants. J. Inherit. Metab. Dis. 2018, 41, 297–307, doi:10.1007/s10545-018-0146-7. 
147.  Lee, J.-S.; Lee, J.Y.; Song, D.W.; Bae, H.S.; Doo, H.M.; Yu, H.S.; Lee, K.J.; Kim, H.K.; 
Hwang, H.; Kwak, G.; et al. Targeted PMP22 TATA-box editing by CRISPR/Cas9 
reduces demyelinating neuropathy of Charcot-Marie-Tooth disease type 1A in mice. 
Nucleic Acids Res. 2019, 48, 130–140, doi:10.1093/nar/gkz1070. 
148.  Gurda, B.L.; Bradbury, A.M.; Vite, C.H. Canine and Feline Models of Human Genetic 
Diseases and Their Contributions to Advancing Clinical Therapies . Yale J. Biol. Med. 
2017, 90, 417–431. 
149.  Katz, M.L.; Coates, J.R.; Sibigtroth, C.M.; Taylor, J.D.; Carpentier, M.; Young, W.M.; 
Wininger, F.A.; Kennedy, D.; Vuillemenot, B.R.; O’Neill, C.A. Enzyme replacement 
therapy attenuates disease progression in a canine model of late‐infantile neuronal 
ceroid lipofuscinosis (CLN2 disease). J. Neurosci. Res. 2014, 92, 1591–1598, 
doi:10.1002/jnr.23423. 
150.  Katz, M.L.; Tecedor, L.; Chen, Y.; Williamson, B.G.; Lysenko, E.; Wininger, F.A.; 
Young, W.M.; Johnson, G.C.; Whiting, R.E.H.; Coates, J.R.; et al. AAV gene transfer 
delays disease onset in a TPP1-deficient canine model of the late infantile form of 
Batten disease. Sci. Transl. Med. 2015, 7, 313ra180-313ra180, 
doi:10.1126/scitranslmed.aac6191. 
151.  Bradbury, A.M.; Rafi, M.A.; Bagel, J.H.; Brisson, B.K.; Marshall, M.S.; Pesayco 
Salvador, J.; Jiang, X.; Swain, G.P.; Prociuk, M.L.; ODonnell, P.A.; et al. AAVrh10 
 
157 
Gene Therapy Ameliorates Central and Peripheral Nervous System Disease in Canine 
Globoid Cell Leukodystrophy (Krabbe Disease). Hum. Gene Ther. 2018, 29, 785–801, 
doi:10.1089/hum.2017.151. 
152.  Bauer, A.; Waluk, D.P.; Galichet, A.; Timm, K.; Jagannathan, V.; Sayar, B.S.; Wiener, 
D.J.; Dietschi, E.; Muller, E.J.; Roosje, P.; et al. A de novo variant in the ASPRV1 
gene in a dog with ichthyosis. PLoS Genet. 2017, 13, e1006651, 
doi:10.1371/journal.pgen.1006651. 
153.  Christiansen, H.E.; Schwarze, U.; Pyott, S.M.; AlSwaid, A.; Al Balwi, M.; Alrasheed, S.; 
Pepin, M.G.; Weis, M.A.; Eyre, D.R.; Byers, P.H. Homozygosity for a Missense 
Mutation in SERPINH1, which Encodes the Collagen Chaperone Protein HSP47, 
Results in Severe Recessive Osteogenesis Imperfecta. Am. J. Hum. Genet. 2010, 86, 
389–398, doi:10.1016/j.ajhg.2010.01.034. 
154.  Boyden, L.M.; Zhou, J.; Hu, R.; Zaki, T.; Loring, E.; Scott, J.; Traupe, H.; Paller, A.S.; 
Lifton, R.P.; Choate, K.A. Mutations in ASPRV1 Cause Dominantly Inherited 
Ichthyosis. Am. J. Hum. Genet. 2020, 107, 158–163, doi:10.1016/j.ajhg.2020.05.013. 
155.  Mauler, D.A.; Gandolfi, B.; Reinero, C.R.; Spooner, J.L.; Lyons, L.A.; 99 Lives 
Consortium Precision Medicine in Cats: Novel Niemann-Pick Type C1 Diagnosed by 
Whole-Genome Sequencing. J. Vet. Intern. Med. 2017, 539–544, 
doi:10.1111/jvim.14599. 
156.  Brunetti, B.; Muscatello, L. V.; Letko, A.; Papa, V.; Cenacchi, G.; Grillini, M.; Murgiano, 
L.; Jagannathan, V.; Drögemüller, C. X-Linked Duchenne-Type Muscular Dystrophy in 
Jack Russell Terrier Associated with a Partial Deletion of the Canine DMD Gene. 
Genes (Basel). 2020, 11, 1175, doi:10.3390/genes11101175. 
157.  Margolis, C.A.; Schneider, P.; Huttner, K.; Kirby, N.; Houser, T.P.; Wildman, L.; Grove, 
G.L.; Schneider, H.; Casal, M.L. Prenatal Treatment of X-Linked Hypohidrotic 
Ectodermal Dysplasia using Recombinant Ectodysplasin in a Canine Model. J. 
Pharmacol. Exp. Ther. 2019, 370, 806–813, doi:10.1124/jpet.118.256040. 
  
 




Last name, first name:  
 






I hereby declare that this thesis represents my original work and that I have used no other 
sources except as noted by citations. 
All data, tables, figures and text citations which have been reproduced from any other 
source, including the internet, have been explicitly acknowledged as such. 
I am aware that in case of non-compliance, the Senate is entitled to withdraw the doctorate 
degree awarded to me on the basis of the present thesis, in accordance with the “Statut der 

















Anna Letko Digitally signed by Anna Letko Date: 2021.03.22 13:52:22 +01'00'
